AU2010260304A1 - DIG-10 insecticidal Cry toxins - Google Patents
DIG-10 insecticidal Cry toxins Download PDFInfo
- Publication number
- AU2010260304A1 AU2010260304A1 AU2010260304A AU2010260304A AU2010260304A1 AU 2010260304 A1 AU2010260304 A1 AU 2010260304A1 AU 2010260304 A AU2010260304 A AU 2010260304A AU 2010260304 A AU2010260304 A AU 2010260304A AU 2010260304 A1 AU2010260304 A1 AU 2010260304A1
- Authority
- AU
- Australia
- Prior art keywords
- seq
- amino acid
- polypeptide
- dig
- toxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108700003918 Bacillus Thuringiensis insecticidal crystal Proteins 0.000 title abstract description 19
- 230000000749 insecticidal effect Effects 0.000 title description 47
- 239000003053 toxin Substances 0.000 claims abstract description 143
- 231100000765 toxin Toxicity 0.000 claims abstract description 143
- 241000607479 Yersinia pestis Species 0.000 claims abstract description 34
- 230000009261 transgenic effect Effects 0.000 claims abstract description 30
- 241000196324 Embryophyta Species 0.000 claims description 128
- 241000238631 Hexapoda Species 0.000 claims description 81
- 238000000034 method Methods 0.000 claims description 59
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 47
- 108020004414 DNA Proteins 0.000 claims description 41
- 238000012217 deletion Methods 0.000 claims description 41
- 230000037430 deletion Effects 0.000 claims description 41
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 37
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 37
- 229920001184 polypeptide Polymers 0.000 claims description 36
- 239000012634 fragment Substances 0.000 claims description 33
- 230000000694 effects Effects 0.000 claims description 26
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 25
- 150000007523 nucleic acids Chemical class 0.000 claims description 25
- 230000014509 gene expression Effects 0.000 claims description 24
- 102000039446 nucleic acids Human genes 0.000 claims description 20
- 108020004707 nucleic acids Proteins 0.000 claims description 20
- 238000006467 substitution reaction Methods 0.000 claims description 19
- 241000193388 Bacillus thuringiensis Species 0.000 claims description 18
- 229940097012 bacillus thuringiensis Drugs 0.000 claims description 17
- 125000003729 nucleotide group Chemical group 0.000 claims description 17
- 239000002773 nucleotide Substances 0.000 claims description 16
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 13
- 235000005822 corn Nutrition 0.000 claims description 13
- 230000004048 modification Effects 0.000 claims description 11
- 238000012986 modification Methods 0.000 claims description 11
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 9
- 230000002411 adverse Effects 0.000 claims description 6
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims description 5
- 108700039887 Essential Genes Proteins 0.000 claims description 5
- -1 EF-laL Proteins 0.000 claims description 3
- 102000011731 Vacuolar Proton-Translocating ATPases Human genes 0.000 claims description 3
- 108010037026 Vacuolar Proton-Translocating ATPases Proteins 0.000 claims description 3
- 230000001629 suppression Effects 0.000 claims description 3
- 102000036801 ADP-Ribosylation Factor 1 Human genes 0.000 claims description 2
- 108010016281 ADP-Ribosylation Factor 1 Proteins 0.000 claims description 2
- 102100031266 Chromodomain-helicase-DNA-binding protein 3 Human genes 0.000 claims description 2
- 101100054775 Drosophila melanogaster Act42A gene Proteins 0.000 claims description 2
- 101000777071 Homo sapiens Chromodomain-helicase-DNA-binding protein 3 Proteins 0.000 claims description 2
- 102000004408 Transcription factor TFIIB Human genes 0.000 claims description 2
- 108090000941 Transcription factor TFIIB Proteins 0.000 claims description 2
- 241000209149 Zea Species 0.000 claims 2
- 108700012359 toxins Proteins 0.000 abstract description 148
- 108091033319 polynucleotide Proteins 0.000 abstract description 4
- 102000040430 polynucleotide Human genes 0.000 abstract description 4
- 239000002157 polynucleotide Substances 0.000 abstract description 4
- 108090000623 proteins and genes Proteins 0.000 description 207
- 102000004169 proteins and genes Human genes 0.000 description 142
- 235000018102 proteins Nutrition 0.000 description 135
- 235000001014 amino acid Nutrition 0.000 description 52
- 229940024606 amino acid Drugs 0.000 description 48
- 150000001413 amino acids Chemical class 0.000 description 48
- 210000004027 cell Anatomy 0.000 description 45
- 238000009396 hybridization Methods 0.000 description 28
- 108091026890 Coding region Proteins 0.000 description 27
- 241000489947 Diabrotica virgifera virgifera Species 0.000 description 27
- 108091028043 Nucleic acid sequence Proteins 0.000 description 27
- 102000035195 Peptidases Human genes 0.000 description 27
- 108091005804 Peptidases Proteins 0.000 description 27
- 239000000523 sample Substances 0.000 description 26
- 230000009466 transformation Effects 0.000 description 26
- 239000004365 Protease Substances 0.000 description 25
- 240000008042 Zea mays Species 0.000 description 25
- 239000013598 vector Substances 0.000 description 24
- 108020004705 Codon Proteins 0.000 description 22
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 22
- 239000013612 plasmid Substances 0.000 description 21
- 239000002609 medium Substances 0.000 description 19
- 241000589158 Agrobacterium Species 0.000 description 18
- 239000000243 solution Substances 0.000 description 17
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000004166 bioassay Methods 0.000 description 15
- 239000011159 matrix material Substances 0.000 description 15
- 239000008188 pellet Substances 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 14
- 235000019419 proteases Nutrition 0.000 description 14
- 108020003175 receptors Proteins 0.000 description 14
- 102000005962 receptors Human genes 0.000 description 14
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 13
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 12
- 239000000499 gel Substances 0.000 description 12
- 210000003000 inclusion body Anatomy 0.000 description 12
- 235000009973 maize Nutrition 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 230000027455 binding Effects 0.000 description 11
- 235000005911 diet Nutrition 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 239000011148 porous material Substances 0.000 description 11
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 10
- 125000000539 amino acid group Chemical group 0.000 description 10
- 238000004422 calculation algorithm Methods 0.000 description 10
- 230000037213 diet Effects 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 10
- 239000004009 herbicide Substances 0.000 description 10
- 229930182817 methionine Natural products 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 10
- 241000254173 Coleoptera Species 0.000 description 9
- 241000258916 Leptinotarsa decemlineata Species 0.000 description 9
- 241000589540 Pseudomonas fluorescens Species 0.000 description 9
- 239000003550 marker Substances 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 241000256247 Spodoptera exigua Species 0.000 description 8
- 238000010367 cloning Methods 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- 230000018109 developmental process Effects 0.000 description 8
- 238000003780 insertion Methods 0.000 description 8
- 230000037431 insertion Effects 0.000 description 8
- 244000005700 microbiome Species 0.000 description 8
- 108091008146 restriction endonucleases Proteins 0.000 description 8
- 241000219194 Arabidopsis Species 0.000 description 7
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 7
- 108700026244 Open Reading Frames Proteins 0.000 description 7
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 7
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 7
- 241000255993 Trichoplusia ni Species 0.000 description 7
- 238000007792 addition Methods 0.000 description 7
- 229940098773 bovine serum albumin Drugs 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 238000003776 cleavage reaction Methods 0.000 description 7
- 239000002158 endotoxin Substances 0.000 description 7
- 230000004927 fusion Effects 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 230000001418 larval effect Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000007017 scission Effects 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 125000006850 spacer group Chemical group 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 102000005600 Cathepsins Human genes 0.000 description 6
- 108010084457 Cathepsins Proteins 0.000 description 6
- 102000005927 Cysteine Proteases Human genes 0.000 description 6
- 108010005843 Cysteine Proteases Proteins 0.000 description 6
- 241000489976 Diabrotica undecimpunctata howardi Species 0.000 description 6
- 241001147398 Ostrinia nubilalis Species 0.000 description 6
- 241000500437 Plutella xylostella Species 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 6
- 230000000368 destabilizing effect Effects 0.000 description 6
- 238000004520 electroporation Methods 0.000 description 6
- 210000002257 embryonic structure Anatomy 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 230000009036 growth inhibition Effects 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 230000002797 proteolythic effect Effects 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 241000566547 Agrotis ipsilon Species 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 108700010070 Codon Usage Proteins 0.000 description 5
- 241000489972 Diabrotica barberi Species 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 206010035226 Plasma cell myeloma Diseases 0.000 description 5
- 241000256251 Spodoptera frugiperda Species 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000004071 biological effect Effects 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 239000013613 expression plasmid Substances 0.000 description 5
- 230000002363 herbicidal effect Effects 0.000 description 5
- 210000004408 hybridoma Anatomy 0.000 description 5
- 230000002163 immunogen Effects 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 239000003112 inhibitor Substances 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 201000000050 myeloid neoplasm Diseases 0.000 description 5
- 230000000361 pesticidal effect Effects 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 229910001415 sodium ion Inorganic materials 0.000 description 5
- 239000002689 soil Substances 0.000 description 5
- 229960000268 spectinomycin Drugs 0.000 description 5
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 5
- 229960005322 streptomycin Drugs 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 4
- 241001587738 Cyclocephala borealis Species 0.000 description 4
- 241000879145 Diatraea grandiosella Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 229920002148 Gellan gum Polymers 0.000 description 4
- 244000299507 Gossypium hirsutum Species 0.000 description 4
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 241000286134 Phyllophaga crinita Species 0.000 description 4
- 241000254101 Popillia japonica Species 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 108010022999 Serine Proteases Proteins 0.000 description 4
- 102000012479 Serine Proteases Human genes 0.000 description 4
- 108700005078 Synthetic Genes Proteins 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical class NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 229960001484 edetic acid Drugs 0.000 description 4
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 241001233957 eudicotyledons Species 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000216 gellan gum Substances 0.000 description 4
- 235000010492 gellan gum Nutrition 0.000 description 4
- 239000012139 lysis buffer Substances 0.000 description 4
- 238000007726 management method Methods 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- HLWRUJAIJJEZDL-UHFFFAOYSA-M sodium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate Chemical compound [Na+].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC([O-])=O HLWRUJAIJJEZDL-UHFFFAOYSA-M 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 3
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 3
- 235000006008 Brassica napus var napus Nutrition 0.000 description 3
- 240000000385 Brassica napus var. napus Species 0.000 description 3
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 3
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 3
- 102000000905 Cadherin Human genes 0.000 description 3
- 108050007957 Cadherin Proteins 0.000 description 3
- 241001124134 Chrysomelidae Species 0.000 description 3
- 108090000317 Chymotrypsin Proteins 0.000 description 3
- 241000489977 Diabrotica virgifera Species 0.000 description 3
- 241000122106 Diatraea saccharalis Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- 241001147381 Helicoverpa armigera Species 0.000 description 3
- 241000255967 Helicoverpa zea Species 0.000 description 3
- 241000256244 Heliothis virescens Species 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- 229930182821 L-proline Natural products 0.000 description 3
- 241000255777 Lepidoptera Species 0.000 description 3
- 241000209510 Liliopsida Species 0.000 description 3
- 241000254043 Melolonthinae Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 3
- 244000061176 Nicotiana tabacum Species 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 241000661452 Sesamia nonagrioides Species 0.000 description 3
- 241000098292 Striacosta albicosta Species 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 230000009418 agronomic effect Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 235000021405 artificial diet Nutrition 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000007640 basal medium Substances 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229960002376 chymotrypsin Drugs 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 102000037865 fusion proteins Human genes 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 238000012224 gene deletion Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000002596 immunotoxin Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 239000002751 oligonucleotide probe Substances 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 229960002429 proline Drugs 0.000 description 3
- 230000020978 protein processing Effects 0.000 description 3
- 231100000654 protein toxin Toxicity 0.000 description 3
- 230000017854 proteolysis Effects 0.000 description 3
- 230000006337 proteolytic cleavage Effects 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 239000012723 sample buffer Substances 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 230000014621 translational initiation Effects 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 2
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical class O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 2
- 108010020183 3-phosphoshikimate 1-carboxyvinyltransferase Proteins 0.000 description 2
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 2
- LKDMKWNDBAVNQZ-UHFFFAOYSA-N 4-[[1-[[1-[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-UHFFFAOYSA-N 0.000 description 2
- 108010000700 Acetolactate synthase Proteins 0.000 description 2
- 102000000452 Acetyl-CoA carboxylase Human genes 0.000 description 2
- 108010016219 Acetyl-CoA carboxylase Proteins 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 101710146995 Acyl carrier protein Proteins 0.000 description 2
- 101710134784 Agnoprotein Proteins 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- 241000242266 Amphimallon majalis Species 0.000 description 2
- 241000254175 Anthonomus grandis Species 0.000 description 2
- 108010017640 Aspartic Acid Proteases Proteins 0.000 description 2
- 102000004580 Aspartic Acid Proteases Human genes 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000223651 Aureobasidium Species 0.000 description 2
- 101000878902 Bacillus thuringiensis Pesticidal crystal protein Cry6Aa Proteins 0.000 description 2
- 101000878906 Bacillus thuringiensis Pesticidal crystal protein Cry6Ba Proteins 0.000 description 2
- 108010077805 Bacterial Proteins Proteins 0.000 description 2
- 241000724266 Broad bean mottle virus Species 0.000 description 2
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 2
- 108090000617 Cathepsin G Proteins 0.000 description 2
- 102000004173 Cathepsin G Human genes 0.000 description 2
- 241001529599 Colaspis brunnea Species 0.000 description 2
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 2
- 101710151559 Crystal protein Proteins 0.000 description 2
- 241000254171 Curculionidae Species 0.000 description 2
- 241001156075 Cyclocephala Species 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- 241000489975 Diabrotica Species 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- 241000462639 Epilachna varivestis Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 239000005562 Glyphosate Substances 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- 241000255990 Helicoverpa Species 0.000 description 2
- 241000498254 Heterodera glycines Species 0.000 description 2
- 241001508564 Hypera punctata Species 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 206010061217 Infestation Diseases 0.000 description 2
- 241000235649 Kluyveromyces Species 0.000 description 2
- 241000966204 Lissorhoptrus oryzophilus Species 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- 102000005741 Metalloproteases Human genes 0.000 description 2
- 108010006035 Metalloproteases Proteins 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241001477931 Mythimna unipuncta Species 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 2
- 125000000729 N-terminal amino-acid group Chemical group 0.000 description 2
- 241000244206 Nematoda Species 0.000 description 2
- 241001160353 Oulema melanopus Species 0.000 description 2
- 102000007079 Peptide Fragments Human genes 0.000 description 2
- 108010033276 Peptide Fragments Proteins 0.000 description 2
- 241000275069 Phyllotreta cruciferae Species 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 108091030071 RNAI Proteins 0.000 description 2
- 241000545593 Scolytinae Species 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 241000589196 Sinorhizobium meliloti Species 0.000 description 2
- 241000254152 Sitophilus oryzae Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 240000003829 Sorghum propinquum Species 0.000 description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 2
- 229940100389 Sulfonylurea Drugs 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000848 Ubiquitin Proteins 0.000 description 2
- 102000044159 Ubiquitin Human genes 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 235000007244 Zea mays Nutrition 0.000 description 2
- 241000314934 Zygogramma exclamationis Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 101150103518 bar gene Proteins 0.000 description 2
- 238000010170 biological method Methods 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 229960004261 cefotaxime Drugs 0.000 description 2
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 2
- 230000006037 cell lysis Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 244000038559 crop plants Species 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000000408 embryogenic effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 230000009368 gene silencing by RNA Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Natural products O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 2
- 102000005396 glutamine synthetase Human genes 0.000 description 2
- 108020002326 glutamine synthetase Proteins 0.000 description 2
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 2
- 229940097068 glyphosate Drugs 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229940029575 guanosine Drugs 0.000 description 2
- 238000003898 horticulture Methods 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 239000011859 microparticle Substances 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 238000002887 multiple sequence alignment Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 101150113864 pat gene Proteins 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 150000008300 phosphoramidites Chemical class 0.000 description 2
- 238000013492 plasmid preparation Methods 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 235000019833 protease Nutrition 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000008653 root damage Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000005030 transcription termination Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- YWBFPKPWMSWWEA-UHFFFAOYSA-O triazolopyrimidine Chemical compound BrC1=CC=CC(C=2N=C3N=CN[N+]3=C(NCC=3C=CN=CC=3)C=2)=C1 YWBFPKPWMSWWEA-UHFFFAOYSA-O 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 235000019354 vermiculite Nutrition 0.000 description 2
- 239000010455 vermiculite Substances 0.000 description 2
- 229910052902 vermiculite Inorganic materials 0.000 description 2
- HXKWSTRRCHTUEC-UHFFFAOYSA-N 2,4-Dichlorophenoxyaceticacid Chemical compound OC(=O)C(Cl)OC1=CC=C(Cl)C=C1 HXKWSTRRCHTUEC-UHFFFAOYSA-N 0.000 description 1
- GOCUAJYOYBLQRH-UHFFFAOYSA-N 2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=NC=C(C(F)(F)F)C=C1Cl GOCUAJYOYBLQRH-UHFFFAOYSA-N 0.000 description 1
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 1
- OOLBCHYXZDXLDS-UHFFFAOYSA-N 2-[4-(2,4-dichlorophenoxy)phenoxy]propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=CC=C(Cl)C=C1Cl OOLBCHYXZDXLDS-UHFFFAOYSA-N 0.000 description 1
- AXAVXPMQTGXXJZ-UHFFFAOYSA-N 2-aminoacetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound NCC(O)=O.OCC(N)(CO)CO AXAVXPMQTGXXJZ-UHFFFAOYSA-N 0.000 description 1
- ABOOPXYCKNFDNJ-UHFFFAOYSA-N 2-{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy}propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=CN=C(C=C(Cl)C=C2)C2=N1 ABOOPXYCKNFDNJ-UHFFFAOYSA-N 0.000 description 1
- UPMXNNIRAGDFEH-UHFFFAOYSA-N 3,5-dibromo-4-hydroxybenzonitrile Chemical compound OC1=C(Br)C=C(C#N)C=C1Br UPMXNNIRAGDFEH-UHFFFAOYSA-N 0.000 description 1
- YREOLPGEVLLKMB-UHFFFAOYSA-N 3-methylpyridin-1-ium-2-amine bromide hydrate Chemical compound O.[Br-].Cc1ccc[nH+]c1N YREOLPGEVLLKMB-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 description 1
- 102100028626 4-hydroxyphenylpyruvate dioxygenase Human genes 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 241000589220 Acetobacter Species 0.000 description 1
- 244000235858 Acetobacter xylinum Species 0.000 description 1
- 235000002837 Acetobacter xylinum Nutrition 0.000 description 1
- 241000495828 Acleris gloverana Species 0.000 description 1
- 241000834107 Acleris variana Species 0.000 description 1
- 241000175828 Adoxophyes orana Species 0.000 description 1
- 241000673185 Aeolus Species 0.000 description 1
- 241001136265 Agriotes Species 0.000 description 1
- 241001136249 Agriotes lineatus Species 0.000 description 1
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
- 241000449794 Alabama argillacea Species 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241001367806 Alsophila pometaria Species 0.000 description 1
- 241000902876 Alticini Species 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 241001259789 Amyelois transitella Species 0.000 description 1
- 241001198505 Anarsia lineatella Species 0.000 description 1
- 241000153204 Anisota senatoria Species 0.000 description 1
- 241000255978 Antheraea pernyi Species 0.000 description 1
- 241000396431 Anthrenus scrophulariae Species 0.000 description 1
- 241000149536 Anthribidae Species 0.000 description 1
- 241000625764 Anticarsia gemmatalis Species 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 241001002469 Archips Species 0.000 description 1
- 241000384127 Argyrotaenia Species 0.000 description 1
- DJHGAFSJWGLOIV-UHFFFAOYSA-K Arsenate3- Chemical compound [O-][As]([O-])([O-])=O DJHGAFSJWGLOIV-UHFFFAOYSA-K 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- 241000589151 Azotobacter Species 0.000 description 1
- 241000589149 Azotobacter vinelandii Species 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 229940123779 Bacterial protease inhibitor Drugs 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 239000005489 Bromoxynil Substances 0.000 description 1
- 241000907223 Bruchinae Species 0.000 description 1
- 241001517925 Bucculatrix Species 0.000 description 1
- 241000726760 Cadra cautella Species 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 102000004225 Cathepsin B Human genes 0.000 description 1
- 108090000712 Cathepsin B Proteins 0.000 description 1
- 102000003908 Cathepsin D Human genes 0.000 description 1
- 108090000258 Cathepsin D Proteins 0.000 description 1
- 102000004175 Cathepsin H Human genes 0.000 description 1
- 108090000619 Cathepsin H Proteins 0.000 description 1
- 101710178430 Cathepsin L-like Proteins 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 241000902406 Chaetocnema Species 0.000 description 1
- 241000343781 Chaetocnema pulicaria Species 0.000 description 1
- 241000255945 Choristoneura Species 0.000 description 1
- 108090000746 Chymosin Proteins 0.000 description 1
- 241000255749 Coccinellidae Species 0.000 description 1
- 241000143939 Colias eurytheme Species 0.000 description 1
- 108010073254 Colicins Proteins 0.000 description 1
- 241000683561 Conoderus Species 0.000 description 1
- 241000993412 Corcyra cephalonica Species 0.000 description 1
- 241000123989 Crambidae Species 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000242268 Ctenicera Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 241001641310 Cunea Species 0.000 description 1
- 241000252867 Cupriavidus metallidurans Species 0.000 description 1
- 241001634817 Cydia Species 0.000 description 1
- 241001635274 Cydia pomonella Species 0.000 description 1
- 102000015833 Cystatin Human genes 0.000 description 1
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- NDUPDOJHUQKPAG-UHFFFAOYSA-N Dalapon Chemical compound CC(Cl)(Cl)C(O)=O NDUPDOJHUQKPAG-UHFFFAOYSA-N 0.000 description 1
- 241001351082 Datana integerrima Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241001631715 Dendrolimus Species 0.000 description 1
- 241000131287 Dermestidae Species 0.000 description 1
- 241001000394 Diaphania hyalinata Species 0.000 description 1
- 241001012951 Diaphania nitidalis Species 0.000 description 1
- 239000005506 Diclofop Substances 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241001517923 Douglasiidae Species 0.000 description 1
- 241001057636 Dracaena deremensis Species 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241001427543 Elateridae Species 0.000 description 1
- 241001105160 Eleodes Species 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241001608224 Ennomos subsignaria Species 0.000 description 1
- 241000661448 Eoreuma loftini Species 0.000 description 1
- 241000122098 Ephestia kuehniella Species 0.000 description 1
- 241001491718 Erannis Species 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- 241000567412 Estigmene acrea Species 0.000 description 1
- 241001201696 Eulia Species 0.000 description 1
- 241000060469 Eupoecilia ambiguella Species 0.000 description 1
- 241000483001 Euproctis chrysorrhoea Species 0.000 description 1
- 241001368778 Euxoa messoria Species 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 108090000331 Firefly luciferases Proteins 0.000 description 1
- 241000255896 Galleria mellonella Species 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 239000005561 Glufosinate Substances 0.000 description 1
- 108700037728 Glycine max beta-conglycinin Proteins 0.000 description 1
- 240000002024 Gossypium herbaceum Species 0.000 description 1
- 235000004341 Gossypium herbaceum Nutrition 0.000 description 1
- 235000009432 Gossypium hirsutum Nutrition 0.000 description 1
- 241001441330 Grapholita molesta Species 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 241000190714 Gymnosporangium clavipes Species 0.000 description 1
- 241001352371 Harrisina americana Species 0.000 description 1
- 241000413128 Hemileuca oliviae Species 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 241000630740 Homoeosoma electellum Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 241000370523 Hypena scabra Species 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010060231 Insect Proteins Proteins 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 239000005571 Isoxaflutole Substances 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- 241000400431 Keiferia lycopersicella Species 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 239000012741 Laemmli sample buffer Substances 0.000 description 1
- 241001658022 Lambdina fiscellaria fiscellaria Species 0.000 description 1
- 241001658020 Lambdina fiscellaria lugubrosa Species 0.000 description 1
- 241001352367 Leucoma salicis Species 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- 241000683448 Limonius Species 0.000 description 1
- 241001261104 Lobesia botrana Species 0.000 description 1
- 241000193981 Loxostege sticticalis Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241000721703 Lymantria dispar Species 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 241000081125 Macalla Species 0.000 description 1
- 241000255676 Malacosoma Species 0.000 description 1
- 241000555303 Mamestra brassicae Species 0.000 description 1
- 241000732113 Mamestra configurata Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000369513 Manduca quinquemaculata Species 0.000 description 1
- 241000255908 Manduca sexta Species 0.000 description 1
- 241001232130 Maruca testulalis Species 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 241001367645 Melanchra picta Species 0.000 description 1
- 241001062280 Melanotus <basidiomycete fungus> Species 0.000 description 1
- 241001143352 Meloidogyne Species 0.000 description 1
- 241000243785 Meloidogyne javanica Species 0.000 description 1
- 239000005578 Mesotrione Substances 0.000 description 1
- 108700005084 Multigene Family Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241001443590 Naganishia albida Species 0.000 description 1
- 241000033319 Naganishia diffluens Species 0.000 description 1
- 101000774651 Naja atra Zinc metalloproteinase-disintegrin-like kaouthiagin-like Proteins 0.000 description 1
- 101710202365 Napin Proteins 0.000 description 1
- 241000486026 Nebris Species 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 101710089395 Oleosin Proteins 0.000 description 1
- 241001491877 Operophtera brumata Species 0.000 description 1
- 241001465800 Orgyia Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 241001585671 Paleacrita vernata Species 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 241001657689 Papaipema nebris Species 0.000 description 1
- 241001300993 Papilio cresphontes Species 0.000 description 1
- 241000222051 Papiliotrema laurentii Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000721451 Pectinophora gossypiella Species 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 101710163504 Phaseolin Proteins 0.000 description 1
- 241001190492 Phryganidia californica Species 0.000 description 1
- 241001517955 Phyllonorycter blancardella Species 0.000 description 1
- 241001313099 Pieris napi Species 0.000 description 1
- 241000907661 Pieris rapae Species 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- 241001608845 Platynota Species 0.000 description 1
- 241001456328 Platynota stultana Species 0.000 description 1
- 241000495716 Platyptilia carduidactyla Species 0.000 description 1
- 241000595629 Plodia interpunctella Species 0.000 description 1
- 241000143945 Pontia protodice Species 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 241001657916 Proxenus mindara Species 0.000 description 1
- 235000005805 Prunus cerasus Nutrition 0.000 description 1
- 241000589615 Pseudomonas syringae Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 241000589180 Rhizobium Species 0.000 description 1
- 241000158450 Rhodobacter sp. KYW73 Species 0.000 description 1
- 241000191043 Rhodobacter sphaeroides Species 0.000 description 1
- 241000190932 Rhodopseudomonas Species 0.000 description 1
- 241000223252 Rhodotorula Species 0.000 description 1
- 241000223253 Rhodotorula glutinis Species 0.000 description 1
- 241000223254 Rhodotorula mucilaginosa Species 0.000 description 1
- 241001510236 Rhyparobia maderae Species 0.000 description 1
- 239000011542 SDS running buffer Substances 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 241000004261 Sabulodes Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000254062 Scarabaeidae Species 0.000 description 1
- 241001351292 Schizura concinna Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 241001135312 Sinorhizobium Species 0.000 description 1
- 241000254181 Sitophilus Species 0.000 description 1
- 241000254179 Sitophilus granarius Species 0.000 description 1
- 241000753145 Sitotroga cerealella Species 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 241000532885 Sphenophorus Species 0.000 description 1
- 241000222068 Sporobolomyces <Sporidiobolaceae> Species 0.000 description 1
- 241000123675 Sporobolomyces roseus Species 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241000254107 Tenebrionidae Species 0.000 description 1
- 244000288561 Torulaspora delbrueckii Species 0.000 description 1
- 235000014681 Torulaspora delbrueckii Nutrition 0.000 description 1
- 241001495125 Torulaspora pretoriensis Species 0.000 description 1
- 241000255985 Trichoplusia Species 0.000 description 1
- 241001351286 Udea rubigalis Species 0.000 description 1
- 241000589634 Xanthomonas Species 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- 241000064240 Yponomeuta padellus Species 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 238000004115 adherent culture Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000006229 amino acid addition Effects 0.000 description 1
- 229960003896 aminopterin Drugs 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940000489 arsenate Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 102000023852 carbohydrate binding proteins Human genes 0.000 description 1
- 108091008400 carbohydrate binding proteins Proteins 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
- 229940080701 chymosin Drugs 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940089639 cornsilk Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000003967 crop rotation Methods 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 108050004038 cystatin Proteins 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000032459 dedifferentiation Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 108091007735 digestive proteases Proteins 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000032669 eclosion Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000000967 entomopathogenic effect Effects 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000002873 global sequence alignment Methods 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000004920 integrated pest control Methods 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- OYIKARCXOQLFHF-UHFFFAOYSA-N isoxaflutole Chemical compound CS(=O)(=O)C1=CC(C(F)(F)F)=CC=C1C(=O)C1=C(C2CC2)ON=C1 OYIKARCXOQLFHF-UHFFFAOYSA-N 0.000 description 1
- 229940088649 isoxaflutole Drugs 0.000 description 1
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 108010083942 mannopine synthase Proteins 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- KPUREKXXPHOJQT-UHFFFAOYSA-N mesotrione Chemical compound [O-][N+](=O)C1=CC(S(=O)(=O)C)=CC=C1C(=O)C1C(=O)CCCC1=O KPUREKXXPHOJQT-UHFFFAOYSA-N 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 108091040857 miR-604 stem-loop Proteins 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 210000000110 microvilli Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- GNOLWGAJQVLBSM-UHFFFAOYSA-N n,n,5,7-tetramethyl-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=C(C)C=C2C(N(C)C)CCCC2=C1C GNOLWGAJQVLBSM-UHFFFAOYSA-N 0.000 description 1
- 210000004898 n-terminal fragment Anatomy 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000014075 nitrogen utilization Effects 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 108010020708 plasmepsin Proteins 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 230000010152 pollination Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 101150116440 pyrF gene Proteins 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 108010038196 saccharide-binding proteins Proteins 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- RWVGQQGBQSJDQV-UHFFFAOYSA-M sodium;3-[[4-[(e)-[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]-2-methylcyclohexa-2,5-dien-1-ylidene]methyl]-n-ethyl-3-methylanilino]methyl]benzenesulfonate Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C)C=C1 RWVGQQGBQSJDQV-UHFFFAOYSA-M 0.000 description 1
- ALZJERAWTOKHNO-UHFFFAOYSA-M sodium;dodecyl sulfate;3-morpholin-4-ylpropane-1-sulfonic acid Chemical compound [Na+].OS(=O)(=O)CCCN1CCOCC1.CCCCCCCCCCCCOS([O-])(=O)=O ALZJERAWTOKHNO-UHFFFAOYSA-M 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000012536 storage buffer Substances 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000007888 toxin activity Effects 0.000 description 1
- 230000024033 toxin binding Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 230000001810 trypsinlike Effects 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- 239000001231 zea mays silk Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8286—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
- C07K14/325—Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Pest Control & Pesticides (AREA)
- Insects & Arthropods (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Catching Or Destruction (AREA)
Abstract
DIG-10 Cry toxins, polynucleotides encoding such toxins, use of such toxins to control pests, and transgenic plants that produce such toxins are disclosed.
Description
WO 2010/147879 PCT/US2010/038482 DIG-10 INSECTICIDAL CRY TOXINS Cross-Reference to Related Applications This Application Claims the benefit of U.S. Provisional Application 61/187,436, filed on June 16, 2009, which is expressly incorporated by reference herein. Field of the Invention [0001] This invention concerns new insecticidal Cry toxins and their use to control insects. Background of the Invention [0002] Bacillus thuringiensis (B.t.) is a soil-borne bacterium that produces pesticidal crystal proteins known as delta endotoxins or Cry proteins. Cry proteins are oral intoxicants that function by acting on midgut cells of susceptible insects. Some Cry toxins have been shown to have activity against nematodes. An extensive list of delta endotoxins is maintained and regularly updated at http://www.lifesci.sussex.ac.uk/home/NeilCrickmore/Bt/intro.html. [0003] Western corn rootworm (WCR), Diabrotica virgifera virgifera LeConte, is an economically important corn pest that causes an estimated $1 billion revenue loss each year in North America due to crop yield loss and expenditures for insect management (Metcalf 1986). WCR management practices include crop rotation with soybeans, chemical insecticides and, more recently, transgenic crops expressing B.t. Cry proteins. However, to date only a few examples of B.t. Cry proteins provide commercial levels of efficacy against WCR, including Cry34Abl/Cry35Abl (Ellis et al., 2002), modified Cry3Aal (Walters et al., 2008) and modified Cry3Bb1 (Vaughn et al., 2005). These B.t. proteins are highly effective at preventing WCR corn root damage when produced in the roots of transgenic corn (Moellenbeck et al., 2001, Vaughn et al., 2005, US Patent No. 7361813). [0004] Despite the success of WCR-resistant transgenic corn, several factors create the need to discover and develop new Cry proteins to control WCR. First, although production of the currently-deployed Cry proteins in transgenic corn plants provides robust protection against WCR root damage, thereby protecting grain yield, some WCR adults emerge in artificial infestation trials, indicating less than complete larval insect control. Second, development of resistant insect populations threatens the long-term durability of Cry proteins in rootworm control. Lepidopteran insects resistant to Cry proteins have developed in the field for Plutella xylostella (Tabashnik, 1994), Trichoplusia ni (Janmaat and Myers 2003, 1 WO 2010/147879 PCT/US2010/038482 2005), and Helicoverpa zeae (Tabashnik et al., 2008). Insect resistance to B.t. Cry proteins can develop through several mechanisms (Heckel et al., (2007), Pigott and Ellar, 2007). Multiple receptor protein classes for Cry proteins have been identified within insects, and multiple examples exist within each receptor class. Resistance to a particular Cry protein may develop, for example, by means of a mutation within the toxin-binding portion of a cadherin domain of a receptor protein. A further means of resistance may be mediated through a protoxin-processing protease. Resistance to Cry toxins in species of Lepidoptera has a complex genetic basis, with at least four distinct, major resistance genes. Similarly, multiple genes are predicted to control resistance to Cry toxins in species of Coleoptera. Development of new high potency Cry proteins will provide additional tools for WCR management. Cry proteins with different modes of action can be produced in combination in transgenic corn to prevent the development WCR insect resistance and protect the long term utility of B. t. technology for rootworm control. Brief Summary of the Invention [0005] The present invention provides insecticidal Cry toxins, including the toxin designated herein as DIG-10 as well as variants of DIG-10, nucleic acids encoding these toxins, methods of controlling pests using the toxins, methods of producing the toxins in transgenic host cells, and transgenic plants that express the toxins. The predicted amino acid sequence of the wild type DIG-10 toxin is given in SEQ ID NO:2. [0006] As described in Example 1, a nucleic acid encoding the DIG-10 protein was isolated from a B.t. strain internally designated by Dow AgroSciences LLC as PS184M1. The nucleic acid sequence for the full length coding region was determined, and the full length protein sequence was deduced from the nucleic acid sequence. The DIG-10 toxin has some similarity to Cry7Ab3 (Genbank Accession No.ABX24522 ) and other B. thuringiensis Cry7 type proteins (http://www.lifesci.sussex.ac.uk/home/NeilCrickmore/Bt/intro.html). [0007] Insecticidally active variants of the DIG-10 toxin are also described herein, and are referred to collectively as DIG-10 toxins. [0008] DIG-10 toxins can be used alone or in combination with other Cry toxins, such as Cry34Abl/Cry35Ab1 (DAS-59122-7), Cry3Bb1 (MON88017), Cry3A (MIR604), chimeric Cry1Ab/Cry3Aa (FR8A, WO 2009/121633A1), CryET33 and CryET34, ViplA, Cry1Ia, CryET84, CryET80, CryET76, CryET71, CryET69, CryET75, CryET39, CryET79, and CryET74 to control development of resistant Coleopteran insect populations. 2 WO 2010/147879 PCT/US2010/038482 [0009] DIG-10 toxins may also be used in combination with RNAi methodologies for control of other insect pests. For example, DIG-10 can be used in transgenic plants in combination with a dsRNA for suppression of an essential gene in corn rootworm or an essential gene in an insect pest. Such target genes include, for example, vacuolar ATPase, ARF-1, Act42A, CHD3, EF-lat, and TFIIB. An example of a suitable target gene is vacuolar ATPase, as disclosed in W02007/035650. [0010] In one embodiment the invention provides an isolated DIG-10 toxin polypeptide comprising a core toxin segment selected from the group consisting of (a) a polypeptide comprising the amino acid sequence of residues 97 to 631 of SEQ ID NO:2; (b) a polypeptide comprising an amino acid sequence having at least 90% sequence identity to the amino acid sequence of residues 97 to 631 of SEQ ID NO:2; (c) a polypeptide comprising an amino acid sequence of residues 97 to 631 of SEQ ID NO:2 with up to 20 amino acid substitutions, deletions, or modifications that do not adversely affect expression or activity of the toxin encoded by SEQ ID NO:2; or an insecticidally active fragment thereof. [0011] In another embodiment the invention provides an isolated DIG-10 toxin polypeptide comprising a DIG-10 core toxin segment selected from the group consisting of (a) a polypeptide comprising the amino acid sequence of residues 1 to 631 of SEQ ID NO:2; (b) a polypeptide comprising an amino acid sequence having at least 90% sequence identity to the amino acid sequence of residues 1 to 631 of SEQ ID NO:2; (c) a polypeptide comprising an amino acid sequence of residues 1 to 631 of SEQ ID NO: 2 with up to 20 amino acid substitutions, deletions, or modifications that do not adversely affect expression or activity of the toxin encoded by SEQ ID NO:2; 3 WO 2010/147879 PCT/US2010/038482 or an insecticidally active fragment thereof. [0012] In another embodiment the invention provides an isolated DIG-10 toxin polypeptide comprising a DIG-10 core toxin segment selected from the group consisting of (a) a polypeptide comprising the amino acid sequence of residues 1 to 1131 of SEQ ID NO:2; (b) a polypeptide comprising an amino acid sequence having at least 90% sequence identity to the amino acid sequence of residues 1 to 1131 of SEQ ID NO:2; (c) a polypeptide comprising an amino acid sequence of residues 1 to 1131 of SEQ ID NO:2 with up to 20 amino acid substitutions, deletions, or modifications that do not adversely affect expression or activity of the toxin encoded by SEQ ID NO:2; or an insecticidally active fragment thereof. [0013] In another embodiment the invention provides an isolated DIG-10 toxin polypeptide comprising a DIG-10 core toxin segment selected from the group consisting of (a) a polypeptide comprising the amino acid sequence of residues 97 to 1131 of SEQ ID NO:2; (b) a polypeptide comprising an amino acid sequence having at least 90% sequence identity to the amino acid sequence of residues 97 to 1131 of SEQ ID NO:2; (c) a polypeptide comprising an amino acid sequence of residues 97 to 1131 of SEQ ID NO:2 with up to 20 amino acid substitutions, deletions, or modifications that do not adversely affect expression or activity of the toxin encoded by SEQ ID NO:2; or an insecticidally active fragment thereof. [0014] In another embodiment the invention provides a plant comprising a DIG-10 toxin. 4 WO 2010/147879 PCT/US2010/038482 [0015] In another embodiment the invention provides a method for controlling a pest population comprising contacting said population with a pesticidally effective amount of a DIG-10 toxin [0016] In another embodiment the invention provides an isolated nucleic acid that encodes a DIG-10 toxin. [0017] In another embodiment the invention provides a DNA construct comprising a nucleotide sequence that encodes a DIG-10 toxin operably linked to a promoter that is not derived from Bacillus thuringiensis and is capable of driving expression in a plant. The invention also provides a transgenic plant that comprises the DNA construct stably incorporated into its genome and a method for protecting a plant from a pest comprising introducing the construct into said plant. Brief Description of the Sequences [0018] SEQ ID NO:1 DNA sequence encoding full-length DIG-10 toxin; 3393 nt. [0019] SEQ ID NO:2 Full-length DIG-10 protein sequence; 1131 aa. [0020] SEQ ID NO:3 Maize-optimized DIG-10 core toxin coding region; 1893 nt. [0021] SEQ ID NO:4 CrylAb protoxin segment; 545 aa. [0022] SEQ ID NO:5 Chimeric toxin: DIG-10 Core/CrylAb protoxin segment; 1176 aa. [0023] SEQ ID NO:6 Dicot-optimized DNA sequence encoding the CrylAb protoxin segment; 1635 nt [0024] SEQ ID NO:7 Maize-optimized DNA sequence encoding the CrylAb protoxin segment; 1635 nt Detailed Description of the Invention [0025] DIG-10 Toxins, and insecticidally active variants. In addition to the full length DIG-10 toxin of SEQ ID NO:2, the invention encompasses insecticidally active variants. By the term "variant", applicants intend to include fragments, certain deletion and insertion mutants, and certain fusion proteins. DIG-10 is a classic three-domain Cry toxin. As a preface to describing variants of the DIG-10 toxin that are included in the invention, it will be useful to briefly review the architecture of three-domain Cry toxins in general and of the DIG 10 protein toxin in particular. [0026] A majority of Bacillus thuringiensis delta-endotoxin crystal protein molecules are composed of two functional segments. The protease-resistant core toxin is the first segment 5 WO 2010/147879 PCT/US2010/038482 and corresponds to about the first half of the protein molecule. The full -130 kDa protoxin molecule is rapidly processed to the resistant core segment by proteases in the insect gut. The segment that is deleted by this processing will be referred to herein as the "protoxin segment." The protoxin segment is believed to participate in toxin crystal formation (Arvidson et al., (1989). The protoxin segment may thus convey a partial insect specificity for the toxin by limiting the accessibility of the core to the insect by reducing the protease processing of the toxin molecule (Haider et al., (1986) or by reducing toxin solubility (Aronson et al., (1991). B.t. toxins, even within a certain class, vary to some extent in length and in the precise location of the transition from the core toxin portion to protoxin portion. The transition from core toxin portion to protoxin portion will typically occur at between about 50% to about 60% of the full length toxin. SEQ ID NO:2 discloses the 1131 amino acid sequence of the full length DIG-10 polypeptide, of which the N-terminal 631 amino acids comprise the DIG-10 core toxin. The 5'-terminal 1893 nucleotides of SEQ ID NO:1 is the coding region for the core toxin. [0027] Three dimensional crystal structures have been determined for CrylAal, Cry2Aal, Cry3Aal, Cry3Bbl, Cry4Aa, Cry4Ba and Cry8Eal. These structures for the core toxins are remarkably similar and are comprised of three distinct domains with the features described below (reviewed in de Maagd et al., 2003). [0028] Domain I is a bundle of seven alpha helices where helix five is surrounded by six amphipathic helices. This domain has been implicated in pore formation and shares homology with other pore forming proteins including hemolysins and colicins. Domain I of the DIG-10 protein comprises amino acid residues 36 to 262 of SEQ ID NO:2. [0029] Domain II is formed by three anti-parallel beta sheets packed together in a beta prism. The loops of this domain play important roles in binding insect midgut receptors. In CrylA proteins, surface exposed loops at the apices of domain II beta sheets are involved in binding to Lepidopteran cadherin receptors. Cry3Aa domain II loops bind a membrane associated metalloprotease of Leptinotarsa decemlineata (Say) (Colorado potato beetle) in a similar fashion (Ochoa-Campuzano et al., 2007). Domain II shares homology with certain carbohydrate-binding proteins including vitelline and jacaline. Domain II of the DIG-10 protein comprises amino acid residues 267 to 476 of SEQ ID NO:2. [0030] Domain III is a beta sandwich of two anti-parallel beta sheets. Structurally this domain is related to carbohydrate-binding domains of proteins such as glucanases, galactose 6 WO 2010/147879 PCT/US2010/038482 oxidase, sialidase and others. Domain III binds certain classes of receptor proteins and perhaps participates in insertion of an oligomeric toxin pre-pore that interacts with a second class of receptors, examples of which are aminopeptidase and alkaline phosphatase in the case of CrylA proteins (Hon6e et al., (1991), Pigott and Ellar, 2007)). Analogous Cry Domain III receptors have yet to be identified in Coleoptera. Conserved B.t. sequence blocks 2 and 3 map near the N-terminus and C-terminus of Domain 2, respectively. Hence, these conserved sequence blocks 2 and 3 are approximate boundary regions between the three functional domains. These regions of conserved DNA and protein homology have been exploited for engineering recombinant B.t. toxins (US Patent No. 6,090,931, WO 91/01087, WO 95/06730, WO 1998022595). Domain III of the DIG-10 protein comprises amino acid residues 486 to 629 of SEQ ID NO:2. [0031] It has been reported that a-helix 1 of domain I is removed following receptor binding. Aronson et al. (1999) demonstrated that CrylAc bound to BBMV was protected from proteinase K cleavage beginning at residue 59, just after a-helix 1; similar results were cited for CrylAb. Gomez et al., (2002) found that CrylAb oligomers formed upon BBMV receptor binding lacked the a-helix 1 portion of domain I. Also, Soberon et al., (2007) have shown that N-terminal deletion mutants of CrylAb and CrylAc which lack approximately 60 amino acids encompassing a-helix 1 on the three dimensional Cry structure are capable of assembling monomers of molecular weight about 60 kDa into pre-pores in the absence of cadherin binding. These N-terminal deletion mutants were reported to be active on Cry resistant insect larvae. Furthermore, Diaz-Mendoza et al., (2007) described CrylAb fragments of 43 kDa and 46 kDa that retained activity on Mediterranean corn borer (Sesamia nonagrioides). These fragments were demonstrated to include amino acid residues 116 to 423; however the precise amino acid sequences were not elucidated and the mechanism of activity of these proteolytic fragments is unknown. The results of Gomez et al., (2002), Soberon et al., 2007 and Diaz-Mendoza et al., (2007) contrast with those of Hofte et al., (1986), who reported that deletion of 36 amino acids from the N-terminus of CrylAb resulted in loss of insecticidal activity. [0032] We have deduced the beginning and end of helices 1, 2A, 2B, and 3, and the location of the spacer regions between them in Domain I of the DIG-10 toxin by comparing the DIG-10 protein sequence with the protein sequence for Cry8Eal, for which the structure is known. These locations are described in Table 1. 7 WO 2010/147879 PCT/US2010/038482 [0033] Table 1. Amino acid coordinates of projected u-helices of DIG-10 protein. Helix1 spacer Helix2A spacer Helix2B spacer Helix3 spacer Helix4 ResidD No2 31-49 50-55 56-70 71-79 80-89 90-96 97-126 127-130 131-151 [0034] Amino terminal deletion variants of DIG-10. In one of its aspects the invention provides DIG-10 variants in which all or part of helices 1, 2A, and 2B are deleted to improve insecticidal activity and avoid development of resistance by insects. These modifications are made to provide DIG-10 variants with improved attributes, such as improved target pest spectrum, potency, and insect resistance management. In some embodiments of the subject invention, the subject modifications may affect the efficiency of protoxin activation and pore formation, leading to insect intoxication. More specifically, to provide DIG-10 variants with improved attributes, step-wise deletions are described that remove part of the gene encoding the N-terminus. The deletions remove all of u-helix 1 and all or part of u-helix 2 in Domain I, while maintaining the structural integrity of the u-helices 3 through 7. The subject invention therefore relates in part to improvements to Cry protein efficacy made by engineering the u-helical components of Domain I for more efficient pore formation. More specifically, the subject invention relates in part to improved DIG-10 proteins designed to have N-terminal deletions in regions with putative secondary structure homology to u-helices 1 and 2 in Domain I of Cryl proteins. [0035] Deletions to improve the insecticidal properties of the DIG-10 toxins may initiate before the predicted u-helix 2A start, and may terminate after the u-helix 2B end, but preferably do not extend into u-helix 3 [0036] In designing coding sequences for the N-terminal deletion variants, an ATG start codon, encoding methionine, is inserted at the 5' end of the nucleotide sequence designed to express the deletion variant. For sequences designed for use in transgenic plants, it may be of benefit to adhere to the "N-end rule" of Varshavsky (1997). It is taught that some amino acids may contribute to protein instability and degradation in eukaryotic cells when displayed as the N-terminal residue of a protein. For example, data collected from observations in yeast and mammalian cells indicate that the N-terminal destabilizing amino acids are F, L, W, Y, R, K, H, I, N, Q, D, E and possibly P. While the specifics of protein degradation mechanisms may differ somewhat between organisms, the conservation of identity of N-terminal destabilizing amino acids seen above suggests that similar mechanisms may function in plant 8 WO 2010/147879 PCT/US2010/038482 cells. For instance, Worley et al., (1998) found that in plants, the N-end rule includes basic and aromatic residues. It is a possibility that proteolytic cleavage by plant proteases near the start of a-helix 3 of subject B.t. insecticidal proteins may expose a destabilizing N-terminal amino acid. Such processing may target the cleaved proteins for rapid decay and limit the accumulation of the B. t. insecticidal proteins to levels insufficient for effective insect control. Accordingly, for N-terminal deletion variants that begin with one of the destabilizing amino acids, applicants prefer to add a codon that specifies a G (glycine) amino acid between the translational initiation methionine and the destabilizing amino acid. [0037] Example 2 gives specific examples of amino-terminal deletion variants of DIG-10 in accordance with the invention. [0038] Chimeric Toxins. Chimeric proteins utilizing the core toxin domain of one Cry toxin fused to the protoxin segment of another Cry toxin have previously been reported. DIG-10 variants include toxins comprising an N-terminal toxin core portion of a DIG-10 toxin (which may be full length or have the N-terminal deletions described above) fused to a heterologous protoxin segment at some point past the end of the core toxin portion. The transition to the heterologous protoxin segment can occur at approximately the core toxin/protoxin junction or, in the alternative, a portion of the native protoxin (extending past the core toxin portion) can be retained with the transition to the heterologous protoxin occurring downstream. As an example, a chimeric toxin of the subject invention has the full toxin portion of DIG-10 (amino acids 1-631) and a heterologous protoxin (amino acids 632 to the C-terminus). In a preferred embodiment, the heterologous portion of the protoxin is derived from a CrylAb delta-endotoxin, as illustrated in SEQ ID NO:5. [0039] SEQ ID NO:4 discloses the 545 amino acid sequence of a CrylAb protoxin segment useful in DIG-10 variants of the invention. Attention is drawn to the last about 100 to 150 amino acids of this protoxin segment, which it is most critical to include in the chimeric toxin of the subject invention. [0040] Protease sensitivity variants. Insect gut proteases typically function in aiding the insect in obtaining needed amino acids from dietary protein. The best understood insect digestive proteases are serine proteases, which appear to be the most common type (Englemann and Geraerts, (1980), particularly in Lepidopteran species. Coleopteran insects have guts that are more neutral to acidic than are Lepidopteran guts. The majority of Coleopteran larvae and adults, for example Colorado potato beetle, have slightly acidic 9 WO 2010/147879 PCT/US2010/038482 midguts, and cysteine proteases provide the major proteolytic activity (Wolfson and Murdock, (1990). More precisely, Thie and Houseman (1990) identified and characterized the cysteine proteases, cathepsin B-like and cathepsin H-like, and the aspartyl protease, cathepsin D-like, in Colorado potato beetle. Gillikin et al., (1992) characterized the proteolytic activity in the guts of western corn rootworm larvae and found primarily cysteine proteases. US Patent No. 7230167 disclosed that the serine protease, cathepsin G, exists in western corn rootworm. The diversity and different activity levels of the insect gut proteases may influence an insect's sensitivity to a particular B.t. toxin. [0041] In another embodiment of the invention, protease cleavage sites may be engineered at desired locations to affect protein processing within the midgut of susceptible larvae of certain insect pests. These protease cleavage sites may be introduced by methods such as chemical gene synthesis or splice overlap PCR (Horton et al., 1989). Serine protease recognition sequences, for example, can optionally be inserted at specific sites in the Cry protein structure to effect protein processing at desired deletion points within the midgut of susceptible larvae. Serine proteases that can be exploited in such fashion include Lepidopteran midgut seine proteases such as trypsin or trypsin-like enzymes, chymotrypsin, elastase, etc. (Christeller et al., 1992). Further, deletion sites identified empirically by sequencing Cry protein digestion products generated with unfractionated larval midgut protease preparations or by binding to brush border membrane vesicles can be engineered to effect protein activation. Modified Cry proteins generated either by gene deletion or by introduction of protease cleavage sites have improved activity on Lepidopteran pests such as Ostrinia nubilalis, Diatraea grandiosella, Helicoverpa zea, Agrotis ipsilon, Spodoptera frugiperda, Spodoptera exigua, Diatraea saccharalis, Loxagrotis albicosta, Coleopteran pests such as western corn rootworm, southern corn root worn, northern corn rootworm (i.e. Diabrotica spp.) and other target pests. [0042] Coleopteran seine proteases such as trypsin, chymotrypsin and cathepsin G-like protease, Coleopteran cysteine proteases such as cathepsins (B-like, L-like, O-like, and K-like proteases) (Koiwa et al., (2000) and Bown et al., (2004), Coleopteran metalloproteases such as ADAM1O (Ochoa-Campuzano et al., (2007)), and Coleopteran aspartic acid proteases such as cathepsins D-like and E-like, pepsin, plasmepsin, and chymosin may further be exploited by engineering appropriate recognition sequences at desired processing sites to affect Cry protein processing within the midgut of susceptible larvae of certain insect pests. 10 WO 2010/147879 PCT/US2010/038482 [0043] A preferred location for the introduction of such protease cleavage sites may be within the "spacer" region between ax-helix2B and a-helix 3, for example within amino acids 90 to 96 of the full length DIG-10 protein (SEQ ID NO:2 and Table 1). A second preferred location for the introduction of protease cleavage sites may be within the spacer region between a-helix3 and a-helix4 (Table 1), for example within amino acids 127 to 130 of the full length DIG-10 protein of SEQ ID NO:2. Modified Cry proteins generated either by gene deletion or by introduction of protease cleavage sites have improved activity on insect pests including but not limited to western corn rootworm, southern corn root worn, northern corn rootworm, and the like. [0044] Various technologies exist to enable determination of the sequence of the amino acids which comprise the N-terminal or C-terminal residues of polypeptides. For example, automated Edman degradation methodology can be used in sequential fashion to determine the N-terminal amino acid sequence of up to 30 amino acid residues with 98% accuracy per residue. Further, determination of the sequence of the amino acids comprising the carboxy end of polypeptides is also possible (Bailey et al., (1992); US Patent No. 6046053). Thus, in some embodiments, B.t. Cry proteins which have been activated by means of proteolytic processing, for example, by proteases prepared from the gut of an insect, may be characterized and the N-terminal or C-terminal amino acids of the activated toxin fragment identified. DIG-10 variants produced by introduction or elimination of protease processing sites at appropriate positions in the coding sequence to allow, or eliminate, proteolytic cleavage of a larger variant protein by insect, plant or microorganism proteases are within the scope of the invention. The end result of such manipulation is understood to be the generation of toxin fragment molecules having the same or better activity as the intact (full length) toxin protein. [0045] Domains of the DIG-10 toxin. The separate domains of the DIG-10 toxin, (and variants that are 90, 95, or 97% identical to such domains) are expected to be useful in forming combinations with domains from other Cry toxins to provide new toxins with increased spectrum of pest toxicity, improved potency, or increased protein stability. Domain I of the DIG-10 protein comprises amino acid residues 36 to 262. Domain II of the DIG-10 protein comprises amino acid residues 267 to 476. Domain III of the DIG-10 protein comprises amino acid residues 486 to 629. Domain swapping or shuffling is another mechanism for generating altered delta-endotoxin proteins. Domains II and III may be 11 WO 2010/147879 PCT/US2010/038482 swapped between delta-endotoxin proteins, resulting in hybrid or chimeric toxins with improved pesticidal activity or target spectrum. Domain II is involved in receptor binding, and Domain III binds certain classes of receptor proteins and perhaps participates in insertion of an oligomeric toxin pre-pore. Some Domain III substitutions in other toxins have been shown to produce superior toxicity against Spodoptera exigua (de Maagd et al., (1996) and guidance exists on the design of the Cry toxin domain swaps (Knight et al., (2004). [0046] Methods for generating recombinant proteins and testing them for pesticidal activity are well known in the art (see, for example, Naimov et al., (2001), de Maagd et al., (1996), Ge et al., (1991), Schnepf et al., (1990), Rang et al., (1999)). Domain I from CrylA and Cry3A proteins has been studied for the ability to insert and form pores in membranes. a-helices 4 and 5 of domain I play key roles in membrane insertion and pore formation (Walters et al., 1993, Gazit et al., 1998; Nunez-Valdez et al., 2001), with the other helices proposed to contact the membrane surface like the ribs of an umbrella (Bravo et al., (2007); Gazit et al., (1998)). [0047] DIG- 10 variants created by making a limited number of amino acid deletions, substitutions, or additions. Amino acid deletions, substitutions, and additions to the amino acid sequence of SEQ ID NO:2 can readily be made in a sequential manner and the effects of such variations on insecticidal activity can be tested by bioassay. Provided the number of changes is limited in number, such testing does not involve unreasonable experimentation. The invention includes insecticidally active variants of the core toxin (amino acids 1-631 of SEQ ID NO:2, or amino acid 97-631 of SEQ ID NO:2) in which up to 10, up to 15, or up to 20 amino acid additions, deletions, or substitutions have been made. [0048] The invention includes DIG-10 variants having a core toxin segment that is 90%, 95% or 97% identical to amino acids 1-631 of SEQ ID NO:2 or amino acids 97-631 of SEQ ID NO:2. [0049] Variants may be made by making random mutations or the variants may be designed. In the case of designed mutants, there is a high probability of generating variants with similar activity to the native toxin when amino acid identity is maintained in critical regions of the toxin which account for biological activity or are involved in the determination of three-dimensional configuration which ultimately is responsible for the biological activity. A high probability of retaining activity will also occur if substitutions are conservative. Amino acids may be placed in the following classes: non-polar, uncharged polar, basic, and 12 WO 2010/147879 PCT/US2010/038482 acidic. Conservative substitutions whereby an amino acid of one class is replaced with another amino acid of the same type are least likely to materially alter the biological activity of the variant. Table 2 provides a listing of examples of amino acids belonging to each class. Table 2. Class of Amino Acid Examples of Amino Acids Nonpolar Side Chains Ala, Val, Leu, Ile, Pro, Met, Phe, Trp Uncharged Polar Side Chains Gly, Ser, Thr, Cys, Tyr, Asn, Gln Acidic Side Chains Asp, Glu Basic Side Chains Lys, Arg, His Beta-branched Side Chains Thr, Val, Ile Aromatic Side Chains Tyr, Phe, Trp, His [0050] In some instances, non-conservative substitutions can also be made. The critical factor is that these substitutions must not significantly detract from the biological activity of the toxin. Variants include polypeptides that differ in amino acid sequence due to mutagenesis. Variant proteins encompassed by the present invention are biologically active, that is they continue to possess the desired biological activity of the native protein, that is, retaining pesticidal activity. [0051] Variant proteins can also be designed that differ at the sequence level but that retain the same or similar overall essential three-dimensional structure, surface charge distribution, and the like. See e.g. US Patent No. 7058515; Larson et al., (2002); Stemmer (1994a,1994b, 1995); and Crameri et al., (1996a, 1996b, 1997). [0052] Nucleic Acids. Isolated nucleic acids encoding DIG-10 toxins are one aspect of the present invention. This includes nucleic acids encoding SEQ ID NO:2 and SEQ ID NO:5, and complements thereof, as well as other nucleic acids that encode insecticidal variants of SEQ ID NO:2. By "isolated" applicants mean that the nucleic acid molecules have been removed from their native environment and have been placed in a different environment by the hand of man. Because of the redundancy of the genetic code, a variety of different DNA sequences can encode the amino acid sequences disclosed herein. It is well within the skill of a person trained in the art to create these alternative DNA sequences encoding the same, or essentially the same, toxins. [0053] Gene synthesis. Genes encoding the improved Cry proteins described herein can be made by a variety of methods well-known in the art. For example, synthetic gene segments and synthetic genes can be made by phosphite tri-ester and phosphoramidite chemistry (Caruthers et al, 1987), and commercial vendors are available to perform gene 13 WO 2010/147879 PCT/US2010/038482 synthesis on demand. Full-length genes can be assembled in a variety of ways including, for example, by ligation of restriction fragments or polymerase chain reaction assembly of overlapping oligonucleotides (Stewart and Burgin, 2005). Further, terminal gene deletions can be made by PCR amplification using site-specific terminal oligonucleotides. [0054] Nucleic acids encoding DIG-10 toxins can be made for example, by synthetic construction by methods currently practiced by any of several commercial suppliers. (See for example, US Patent No. 7482119 B2). These genes, or portions or variants thereof, may also be constructed synthetically, for example, by use of a gene synthesizer and the design methods of, for example, US Patent No. 5380831. Alternatively, variations of synthetic or naturally occurring genes may be readily constructed using standard molecular biological techniques for making point mutations. Fragments of these genes can also be made using commercially available exonucleases or endonucleases according to standard procedures. For example, enzymes such as Bal31 or site-directed mutagenesis can be used to systematically cut off nucleotides from the ends of these genes. Also, gene fragments which encode active toxin fragments may be obtained using a variety of restriction enzymes. [0055] Given the amino acid sequence for a DIG-10 toxin, a coding sequence can be designed by reverse translating the coding sequence using codons preferred by the intended host, and then refining the sequence using alternative codons to remove sequences that might cause problems and provide periodic stop codons to eliminate long open coding sequences in the non-coding reading frames. [0056] Quantifying Sequence Identity. To determine the percent identity of two amino acid sequences or of two nucleic acid sequences, the sequences are aligned for optimal comparison purposes. The percent identity between the two sequences is a function of the number of identical positions shared by the sequences (i.e. percent identity = number of identical positions/total number of positions (e.g. overlapping positions) x100). In one embodiment, the two sequences are the same length. The percent identity between two sequences can be determined using techniques similar to those described below, with or without allowing gaps. In calculating percent identity, typically exact matches are counted. [0057] The determination of percent identity between two sequences can be accomplished using a mathematical algorithm. A nonlimiting example of such an algorithm is that of Altschul et al. (1990), and Karlin and Altschul (1990), modified as in Karlin and Altschul (1993), and incorporated into the BLASTN and BLASTX programs. BLAST searches may 14 WO 2010/147879 PCT/US2010/038482 be conveniently used to identify sequences homologous (similar) to a query sequence in nucleic or protein databases. BLASTN searches can be performed, (score = 100, word length = 12) to identify nucleotide sequences having homology to claimed nucleic acid molecules of the invention. BLASTX searches can be performed (score = 50, word length = 3) to identify amino acid sequences having homology to claimed insecticidal protein molecules of the invention. [0058] Gapped BLAST Altschul et al., (1997) can be utilized to obtain gapped alignments for comparison purposes, Alternatively, PSI-Blast can be used to perform an iterated search that detects distant relationships between molecules Altschul et al., (1997). When utilizing BLAST, Gapped BLAST, and PSI-Blast programs, the default parameters of the respective programs can be used. See www.ncbi.nlm.nih.gov. [0059] A non-limiting example of a mathematical algorithm utilized for the comparison of sequences is the ClustalW algorithm (Thompson et al., (1994). ClustalW compares sequences and aligns the entirety of the amino acid or DNA sequence, and thus can provide data about the sequence conservation of the entire amino acid sequence or nucleotide sequence. The ClustalW algorithm is used in several commercially available DNA/amino acid analysis software packages, such as the ALIGNX module of the Vector NTI Program Suite (Invitrogen, Inc., Carlsbad, CA). When aligning amino acid sequences with ALIGNX, one may conveniently use the default settings with a Gap open penalty of 10, a Gap extend penalty of 0.1 and the blosum63mt2 comparison matrix to assess the percent amino acid similarity (consensus) or identity between the two sequences. When aligning DNA sequences with ALIGNX, one may conveniently use the default settings with a Gap open penalty of 15, a Gap extend penalty of 6.6 and the swgapdnamt comparison matrix to assess the percent identity between the two sequences. [0060] Another non-limiting example of a mathematical algorithm utilized for the comparison of sequences is that of Myers and Miller (1988). Such an algorithm is incorporated into the wSTRETCHER program, which is part of the wEMBOSS sequence alignment software package (available at http://emboss.sourceforge.net/). wSTRETCHER calculates an optimal global alignment of two sequences using a modification of the classic dynamic programming algorithm which uses linear space. The substitution matrix, gap insertion penalty and gap extension penalties used to calculate the alignment may be specified. When utilizing the wSTRETCHER program for comparing nucleotide sequences, 15 WO 2010/147879 PCT/US2010/038482 a Gap open penalty of 16 and a Gap extend penalty of 4 can be used with the scoring matrix file EDNAFULL. When used for comparing amino acid sequences, a Gap open penalty of 12 and a Gap extend penalty of 2 can be used with the EBLOSUM62 scoring matrix file. [0061] A further non-limiting example of a mathematical algorithm utilized for the comparison of sequences is that of Needleman and Wunsch (1970), which is incorporated in the sequence alignment software packages GAP Version 10 and wNEEDLE (http://emboss.sourceforge.net/). GAP Version 10 may be used to determine sequence identity or similarity using the following parameters: for a nucleotide sequence, % identity and % similarity are found using GAP Weight of 50 and Length Weight of 3, and the nwsgapdna. cmp scoring matrix. For amino acid sequence comparison, % identity or % similarity are determined using GAP weight of 8 and length weight of 2, and the BLOSUM62 scoring program. [0062] wNEEDLE reads two input sequences, finds the optimum alignment (including gaps) along their entire length, and writes their optimal global sequence alignment to file. The algorithm explores all possible alignments and chooses the best, using .a scoring matrix that contains values for every possible residue or nucleotide match. wNEEDLE finds the alignment with the maximum possible score, where the score of an alignment is equal to the sum of the matches taken from the scoring matrix, minus penalties arising from opening and extending gaps in the aligned sequences. The substitution matrix and gap opening and extension penalties are user-specified. When amino acid sequences are compared, a default Gap open penalty of 10, a Gap extend penalty of 0.5, and the EBLOSUM62 comparison matrix are used. When DNA sequences are compared using wNEEDLE, a Gap open penalty of 10, a Gap extend penalty of 0.5, and the EDNAFULL comparison matrix are used. [0063] Equivalent programs may also be used. By "equivalent program" is intended any sequence comparison program that, for any two sequences in question, generates an alignment having identical nucleotide or amino acid residue matches and an identical percent sequence identity when compared to the corresponding alignment generated by ALIGNX, wNEEDLE, or wSTRETCHER. The % identity is the percentage of identical matches between the two sequences over the reported aligned region (including any gaps in the length) and the % similarity is the percentage of matches between the two sequences over the reported aligned region (including any gaps in the length). [0064] Alignment may also be performed manually by inspection. 16 WO 2010/147879 PCT/US2010/038482 [0065] Recombinant hosts. The toxin-encoding genes of the subject invention can be introduced into a wide variety of microbial or plant hosts. Expression of the toxin gene results, directly or indirectly, in the intracellular production and maintenance of the pesticidal protein. With suitable microbial hosts, e.g. Pseudomonas, the microbes can be applied to the environment of the pest, where they will proliferate and be ingested. The result is a control of the pest. Alternatively, the microbe hosting the toxin gene can be treated under conditions that prolong the activity of the toxin and stabilize the cell. The treated cell, which retains the toxic activity, then can be applied to the environment of the target pest. [0066] Where the B.t. toxin gene is introduced via a suitable vector into a microbial host, and said host is applied to the environment in a living state, it is essential that certain host microbes be used. Microorganism hosts are selected which are known to occupy the "phytosphere" (phylloplane, phyllosphere, rhizosphere, and/or rhizoplane) of one or more crops of interest. These microorganisms are selected so as to be capable of successfully competing in the particular environment (crop and other insect habitats) with the wild-type indigenous microorganisms, provide for stable maintenance and expression of the gene expressing the polypeptide pesticide, and, desirably, provide for improved protection of the pesticide from environmental degradation and inactivation. [0067] A large number of microorganisms are known to inhabit the phylloplane (the surface of the plant leaves) and/or the rhizosphere (the soil surrounding plant roots) of a wide variety of important crops. These microorganisms include bacteria, algae, and fungi. Of particular interest are microorganisms, such as bacteria, e.g. genera Pseudomonas, Erwinia, Serratia, Klebsiella, Xanthomonas, Streptomyces, Rhizobium, Sinorhizobium, Rhodopseudomonas, Methylophilius, Agrobacterium, Acetobacter, Lactobacillus, Arthrobacter, Azotobacter, Leuconostoc, and Alcaligenes; fungi, particularly yeast, e.g. genera Saccharomyces, Cryptococcus, Kluyveromyces, Sporobolomyces, Rhodotorula, and Aureobasidium. Of particular interest are such phytosphere bacterial species as Pseudomonas syringae, Pseudomonas fluorescens, Serratia marcescens, Acetobacter xylinum, Agrobacterium tumefaciens, Agrobacterium radiobacter, Rhodopseudomonas spheroides, Xanthomonas campestris, Sinorhizobium meliloti (formerly Rhizobium meliloti), Alcaligenes eutrophus, and Azotobacter vinelandii; and phytosphere yeast species such as Rhodotorula rubra, R. glutinis, R. marina, R. aurantiaca, Cryptococcus albidus, C. diffluens, C. laurentii, Saccharomyces rosei, S. pretoriensis, S. cerevisiae, Sporobolomyces roseus, S. 17 WO 2010/147879 PCT/US2010/038482 odorus, Kluyveromyces veronae, and Aureobasidium pollulans. Of particular interest are the pigmented microorganisms. Methods of controlling insect pests [0068] When an insect comes into contact with an effective amount of toxin delivered via transgenic plant expression, formulated protein compositions(s), sprayable protein composition(s), a bait matrix or other delivery system, the results are typically death of the insect, or the insects do not feed upon the source which makes the toxins available to the insects. [0069] The subject protein toxins can be "applied" or provided to contact the target insects in a variety of ways. For example, transgenic plants (wherein the protein is produced by and present in the plant) can be used and are well-known in the art. Expression of the toxin genes can also be achieved selectively in specific tissues of the plants, such as the roots, leaves, etc. This can be accomplished via the use of tissue-specific promoters, for example. Spray-on applications are another example and are also known in the art. The subject proteins can be appropriately formulated for the desired end use, and then sprayed (or otherwise applied) onto the plant and/or around the plant / to the vicinity of the plant to be protected - before an infestation is discovered, after target insects are discovered, both before and after, and the like. Bait granules, for example, can also be used and are known in the art. Transgenic plants [0070] The subject proteins can be used to protect practically any type of plant from damage by an insect pest. Examples of such plants include maize, sunflower, soybean, cotton, canola, rice, sorghum, wheat, barley, vegetables, ornamentals, peppers (including hot peppers), sugar beets, fruit, and turf, to name but a few. Methods for transforming plants are well known in the art, and illustrative transformation methods are described in the Examples. [0071] A preferred embodiment of the subject invention is the transformation of plants with genes encoding the subject insecticidal protein or its variants. The transformed plants are resistant to attack by an insect target pest by virtue of the presence of controlling amounts of the subject insecticidal protein or its variants in the cells of the transformed plant. By incorporating genetic material that encodes the insecticidal properties of the B.t. insecticidal toxins into the genome of a plant eaten by a particular insect pest, the adult or larvae would die after consuming the food plant. Numerous members of the monocotyledonous and dicotyledonous classifications have been transformed. Transgenic agronomic crops as well as 18 WO 2010/147879 PCT/US2010/038482 fruits and vegetables are of commercial interest. Such crops include but are not limited to maize, rice, soybeans, canola, sunflower, alfalfa, sorghum, wheat, cotton, peanuts, tomatoes, potatoes, and the like. Several techniques exist for introducing foreign genetic material into plant cells, and for obtaining plants that stably maintain and express the introduced gene. Such techniques include acceleration of genetic material coated onto microparticles directly into cells (US Patent No, 4945050 and US Patent No. 5141131). Plants may be transformed using Agrobacterium technology, see US Patent No. 5177010, US Patent No. 5104310, European Patent Application No. 0131624B1, European Patent Application No. 120516, European Patent Application No. 159418B1, European Patent Application No. 176112, US Patent No. 5149645, US Patent No. 5469976, US Patent No. 5464763, US Patent No. 4940838, US Patent No. 4693976, European Patent Application No. 116718, European Patent Application No. 290799, European Patent Application No. 320500, European Patent Application No. 604662, European Patent Application No. 627752, European Patent Application No. 0267159, European Patent Application No. 0292435, US Patent No. 5231019, US Patent No. 5463174, US Patent No. 4762785, US Patent No. 5004863, and US Patent No. 5159135. Other transformation technology includes WHISKERS TM technology, see US Patent No. 5302523 and US Patent No. 5464765. Electroporation technology has also been used to transform plants, see WO 87/06614, US Patent No. 5472869, US Patent No. 5384253, WO 9209696, and WO 9321335. All of these transformation patents and publications are incorporated by reference. In addition to numerous technologies for transforming plants, the type of tissue which is contacted with the foreign genes may vary as well. Such tissue would include but would not be limited to embryogenic tissue, callus tissue type I and II, hypocotyl, meristem, and the like. Almost all plant tissues may be transformed during dedifferentiation using appropriate techniques within the skill of an artisan. [0072] Genes encoding DIG-10 toxins can be inserted into plant cells using a variety of techniques which are well known in the art as disclosed above. For example, a large number of cloning vectors comprising a marker that permits selection of the transformed microbial cells and a replication system functional in Escherichia coli are available for preparation and modification of foreign genes for insertion into higher plants. Such manipulations may include, for example, the insertion of mutations, truncations, additions, or substitutions as desired for the intended use. The vectors comprise, for example, pBR322, pUC series, M13mp series, pACYC184, etc. Accordingly, the sequence encoding the Cry protein or 19 WO 2010/147879 PCT/US2010/038482 variants can be inserted into the vector at a suitable restriction site. The resulting plasmid is used for transformation of E. coli, the cells of which are cultivated in a suitable nutrient medium, then harvested and lysed so that workable quantities of the plasmid are recovered. Sequence analysis, restriction fragment analysis, electrophoresis, and other biochemical molecular biological methods are generally carried out as methods of analysis. After each manipulation, the DNA sequence used can be cleaved and joined to the next DNA sequence. Each manipulated DNA sequence can be cloned in the same or other plasmids. [0073] The use of T-DNA-containing vectors for the transformation of plant cells has been intensively researched and sufficiently described in European Patent Application No. 120516; Lee and Gelvin (2008), Fraley et al., (1986), and An et al., (1985), and is well established in the field. [0074] Once the inserted DNA has been integrated into the plant genome, it is relatively stable throughout subsequent generations. The vector used to transform the plant cell normally contains a selectable marker gene encoding a protein that confers on the transformed plant cells resistance to a herbicide or an antibiotic, such as bialaphos, kanamycin, G418, bleomycin, or hygromycin, inter alia. The individually employed selectable marker gene should accordingly permit the selection of transformed cells while the growth of cells that do not contain the inserted DNA is suppressed by the selective compound. [0075] A large number of techniques are available for inserting DNA into a host plant cell. Those techniques include transformation with T-DNA delivered by Agrobacterium tumefaciens or Agrobacterium rhizogenes as the transformation agent. Additionally, fusion of plant protoplasts with liposomes containing the DNA to be delivered, direct injection of the DNA, biolistics transformation (microparticle bombardment), or electroporation, as well as other possible methods, may be employed. [0076] In a preferred embodiment of the subject invention, plants will be transformed with genes wherein the codon usage of the protein coding region has been optimized for plants. See, for example, US Patent No. 5380831, which is hereby incorporated by reference. Also, advantageously, plants encoding a truncated toxin will be used. The truncated toxin typically will encode about 55% to about 80% of the full length toxin. Methods for creating synthetic B.t. genes for use in plants are known in the art (Stewart 2007). [0077] Regardless of transformation technique, the gene is preferably incorporated into a gene transfer vector adapted to express the B.t. insecticidal toxin genes and variants in the 20 WO 2010/147879 PCT/US2010/038482 plant cell by including in the vector a plant promoter. In addition to plant promoters, promoters from a variety of sources can be used efficiently in plant cells to express foreign genes. For example, promoters of bacterial origin, such as the octopine synthase promoter, the nopaline synthase promoter, the mannopine synthase promoter; promoters of viral origin, such as the 35S and 19S promoters of cauliflower mosaic virus, and the like may be used. Plant promoters include, but are not limited to ribulose-1,6-bisphosphate (RUBP) carboxylase small subunit (ssu), beta-conglycinin promoter, phaseolin promoter, ADH (alcohol dehydrogenase) promoter, heat-shock promoters, ADF (actin depolymerization factor) promoter, and tissue specific promoters. Promoters may also contain certain enhancer sequence elements that may improve the transcription efficiency. Typical enhancers include but are not limited to ADHI-intron 1 and ADHI-intron 6. Constitutive promoters may be used. Constitutive promoters direct continuous gene expression in nearly all cells types and at nearly all times (e.g., actin, ubiquitin, CaMV 35S). Tissue specific promoters are responsible for gene expression in specific cell or tissue types, such as the leaves or seeds (e.g., zein, oleosin, napin, ACP (Acyl Carrier Protein)), and these promoters may also be used. Promoters may also be used that are active during a certain stage of the plants' development as well as active in specific plant tissues and organs. Examples of such promoters include but are not limited to promoters that are root specific, pollen-specific, embryo specific, corn silk specific, cotton fiber specific, seed endosperm specific, phloem specific, and the like. [0078] Under certain circumstances it may be desirable to use an inducible promoter. An inducible promoter is responsible for expression of genes in response to a specific signal, such as: physical stimulus (e.g. heat shock genes); light (e.g. RUBP carboxylase); hormone (e.g. glucocorticoid); antibiotic (e.g. tetracycline); metabolites; and stress (e.g. drought). Other desirable transcription and translation elements that function in plants may be used, such as 5' untranslated leader sequences, RNA transcription termination sequences and poly adenylate addition signal sequences. Numerous plant-specific gene transfer vectors are known to the art. [0079] Transgenic crops containing insect resistance (IR) traits are prevalent in corn and cotton plants throughout North America, and usage of these traits is expanding globally. Commercial transgenic crops combining IR and herbicide tolerance (HT) traits have been developed by multiple seed companies. These include combinations of IR traits conferred by 21 WO 2010/147879 PCT/US2010/038482 B.t. insecticidal proteins and HT traits such as tolerance to Acetolactate Synthase (ALS) inhibitors such as sulfonylureas, imidazolinones, triazolopyrimidine, sulfonanilides, and the like, Glutamine Synthetase (GS) inhibitors such as bialaphos, glufosinate, and the like, 4 HydroxyPhenylPyruvate Dioxygenase (HPPD) inhibitors such as mesotrione, isoxaflutole, and the like, 5-EnolPyruvylShikimate-3-Phosphate Synthase (EPSPS) inhibitors such as glyphosate and the like, and Acetyl-Coenzyme A Carboxylase (ACCase) inhibitors such as haloxyfop, quizalofop, diclofop, and the like. Other examples are known in which transgenically provided proteins provide plant tolerance to herbicide chemical classes such as phenoxy acids herbicides and pyridyloxyacetates auxin herbicides (see WO 2007/053482 A2), or phenoxy acids herbicides and aryloxyphenoxypropionates herbicides (see WO 2005107437 A2, A3). The ability to control multiple pest problems through IR traits is a valuable commercial product concept, and the convenience of this product concept is enhanced if insect control traits and weed control traits are combined in the same plant. Further, improved value may be obtained via single plant combinations of IR traits conferred by a B.t. insecticidal protein such as that of the subject invention with one or more additional HT traits such as those mentioned above, plus one or more additional input traits (e.g. other insect resistance conferred by B.t.-derived or other insecticidal proteins, insect resistance conferred by mechanisms such as RNAi and the like, disease resistance, stress tolerance, improved nitrogen utilization, and the like), or output traits (e.g. high oils content, healthy oil composition, nutritional improvement, and the like). Such combinations may be obtained either through conventional breeding (breeding stack) or jointly as a novel transformation event involving the simultaneous introduction of multiple genes (molecular stack). Benefits include the ability to manage insect pests and improved weed control in a crop plant that provides secondary benefits to the producer and/or the consumer. Thus, the subject invention can be used in combination with other traits to provide a complete agronomic package of improved crop quality with the ability to flexibly and cost effectively control any number of agronomic issues. Target Pests [0080] The DIG-10 toxins of the invention are particularly suitable for use in control of insects pests. Coleopterans are one important group of agricultural, horticultural, and household pests which cause a very large amount of damage each year. This insect order encompasses foliar- and root-feeding larvae and adults, including: weevils from the families 22 WO 2010/147879 PCT/US2010/038482 Anthribidae, Bruchidae, and Curculionidae [e.g. boll weevil (Anthonomus grandis Boheman), rice water weevil (Lissorhoptrus oryzophilus Kuschel), granary weevil (Sitophilus grananus Linnaeus), rice weevil (Sitophilus oryzae Linnaeus), clover leaf weevil (Hypera punctata Fabricius), and maize billbug (Sphenophorus maidis Chittenden)]; flea beetles, cucumber beetles, rootworms, leaf beetles, potato beetles, and leaf miners in the family Chrysomelidae [e.g. Colorado potato beetle (Leptinotarsa decemlineata Say), western corn rootworm (Diabrotica virgifera virgifera LeConte), northern corn rootworm (Diabrotica barben Smith & Lawrence); southern corn rootworm (Diabrotica undecimpunctata howardi Barber), corn flea beetle (Chaetocnema pulicara Melsheimer), crucifer flea beetle (Phyllotreta cruciferae Goeze), grape colaspis (Colaspis brunnea Fabricius), cereal leaf beetle (Oulema melanopus Linnaeus), and sunflower beetle (Zygogramma exclamationis Fabricius)]; beetles from the family Coccinellidae [e.g. Mexican bean beetle (Epilachna varivestis Mulsant)]; chafers and other beetles from the family Scarabaeidae (e.g. Japanese beetle (Popillia japonica Newman), northern masked chafer (white grub, Cyclocephala borealis Arrow), southern masked chafer (white grub, Cyclocephala immaculata Olivier), European chafer (Rhizotrogus majalis Razoumowsky), white grub (Phyllophaga crinita Burmeister), and carrot beetle (Ligyrus gibbosus De Geer)]; carpet beetles from the family Dermestidae; wireworms from the family Elateridae [e.g. Melanotus spp., Conoderus spp., Limonius spp., Agriotes spp., Ctenicera spp., Aeolus spp.)]; bark beetles from the family Scolytidae, and beetles from the family Tenebrionidae (e.g. Eleodes spp). Any genus listed above (and others), generally, can also be targeted as a part of the subject invention. Any additional insects in any of these genera (as targets) are also included within the scope of this invention. [0081] Lepidopterans are another important group of agricultural, horticultural, and household pests which cause a very large amount of damage each year. This insect order encompasses foliar- and root-feeding larvae and adults. Lepidopteran insect pests include, but are not limited to: Achoroia grisella, Acleris gloverana, Acleris variana, Adoxophyes orana, Agrotis ipsilon (black cutworm), Alabama argillacea, Alsophila pometaria, Amyelois transitella, Anagasta kuehniella, Anarsia lineatella, Anisota senatoria, Antheraea pernyi, Anticarsia gemmatalis, Archips sp., Argyrotaenia sp., Athetis mindara, Bombyx mori, Bucculatrix thurberiella, Cadra cautella, Choristoneura sp., Cochylls hospes, Colias eurytheme, Corcyra cephalonica, Cydia latiferreanus, Cydia pomonella, Datana integerrima, 23 WO 2010/147879 PCT/US2010/038482 Dendrolimus sibericus, Desmiafeneralis, Diaphania hyalinata, Diaphania nitidalis, Diatraea grandiosella (southwestern corn borer), Diatraea saccharalis, Ennomos subsignaria, Eoreuma loftini, Esphestia elutella, Erannis tilaria, Estigmene acrea, Eulia salubricola, Eupocoellia ambiguella, Eupoecilia ambiguella, Euproctis chrysorrhoea, Euxoa messoria, Galleria mellonella, Grapholita molesta, Harrisina americana, Helicoverpa subflexa, Helicoverpa zea (corn earworm), Heliothis virescens, Hemileuca oliviae, Homoeosoma electellum, Hyphantia cunea, Keiferia lycopersicella, Lambdinafiscellaria fiscellaria, Lambdinafiscellaria lugubrosa, Leucoma salicis, Lobesia botrana, Loxagrotis albicosta (western bean cutworm), Loxostege sticticalis, Lymantria dispar, Macalla thyrisalis, Malacosoma sp., Mamestra brassicae, Mamestra configurata, Manduca quinquemaculata, Manduca sexta, Maruca testulalis, Melanchra picta, Operophtera brumata, Orgyia sp., Ostrinia nubilalis (European corn borer), Paleacrita vernata, Papiapema nebris (common stalk borer), Papilio cresphontes, Pectinophora gossypiella, Phryganidia californica, Phyllonorycter blancardella, Pieris napi, Pieris rapae, Plathypena scabra, Platynota flouendana, Platynota stultana, Platyptilia carduidactyla, Plodia interpunctella, Plutella xylostella (diamondback moth), Pontia protodice, Pseudaletia unipuncta (armyworm), Pseudoplasia includens, Sabulodes aegrotata, Schizura concinna, Sitotroga cerealella, Spilonta ocellana, Spodopterafrugiperda (fall armyworm), Spodoptera exigua (beet armyworm), Thaurnstopoea pityocampa, Ensola bisselliella, Trichoplusia hi, Udea rubigalis, Xylomyges curiails, and Yponomeuta padella. [0082] Use of DIG-10 toxins to control Coleopteran pests of crop plants is contemplated. In some embodiments, Cry proteins may be economically deployed for control of insect pests that include but are not limited to, for example, rootworms such as Diabrotica undecimpunctata howardi (southern corn rootworm), Diabrotica longicornis barberi (northern corn rootworm), and Diabrotica virgifera (western corn rootworm), and grubs such as the larvae of Cyclocephala borealis (northern masked chafer),Cyclocephala immaculate (southern masked chafer), and Popilliajaponica (Japanese beetle). [0083] Use of the DIG-10 toxins to control parasitic nematodes including, but not limited to, root knot nematode (Meloidogyne icognita) and soybean cyst nematode (Heterodera glycines) is also contemplated. 24 WO 2010/147879 PCT/US2010/038482 Antibody detection of DIG-10 toxins [0084] Anti-toxin antibodies. Antibodies to the toxins disclosed herein, or to equivalent toxins, or fragments of these toxins, can readily be prepared using standard procedures in this art. Such antibodies are useful to detect the presence of the DIG-10 toxins. [0085] Once the B. t. insecticidal toxin has been isolated, antibodies specific for the toxin may be raised by conventional methods that are well known in the art. Repeated injections into a host of choice over a period of weeks or months will elicit an immune response and result in significant anti-B.t. toxin serum titers. Preferred hosts are mammalian species and more highly preferred species are rabbits, goats, sheep and mice. Blood drawn from such immunized animals may be processed by established methods to obtain antiserum (polyclonal antibodies) reactive with the B.t. insecticidal toxin. The antiserum may then be affinity purified by adsorption to the toxin according to techniques known in the art. Affinity purified antiserum may be further purified by isolating the immunoglobulin fraction within the antiserum using procedures known in the art. The resulting material will be a heterogeneous population of immunoglobulins reactive with the B.t. insecticidal toxin. [0086] Anti-B.t. toxin antibodies may also be generated by preparing a semi-synthetic immunogen consisting of a synthetic peptide fragment of the B.t. insecticidal toxin conjugated to an immunogenic carrier. Numerous schemes and instruments useful for making peptide fragments are well known in the art. Many suitable immunogenic carriers such as bovine serum albumin or keyhole limpet hemocyanin are also well known in the art, as are techniques for coupling the immunogen and carrier proteins. Once the semi-synthetic immunogen has been constructed, the procedure for making antibodies specific for the B.t. insecticidal toxin fragment is identical to those used for making antibodies reactive with natural B.t. toxin. [0087] Anti-B.t. toxin monoclonal antibodies (MAbs) are readily prepared using purified B.t. insecticidal toxin. Methods for producing MAbs have been practiced for over 15 years and are well known to those of ordinary skill in the art. Repeated intraperitoneal or subcutaneous injections of purified B.t. insecticidal toxin in adjuvant will elicit an immune response in most animals. Hyperimmunized B-lymphocytes are removed from the animal and fused with a suitable fusion partner cell line capable of being cultured indefinitely. Preferred animals whose B-lymphocytes may be hyperimmunized and used in the production of MAbs 25 WO 2010/147879 PCT/US2010/038482 are mammals. More preferred animals are rats and mice and most preferred is the BALB/c mouse strain. [0088] Numerous mammalian cell lines are suitable fusion partners for the production of hybridomas. Many such lines are available from the American Type Culture Collection (ATCC, Manassas, VA) and commercial suppliers. Preferred fusion partner cell lines are derived from mouse myelomas and the HL-1@ Friendly myeloma-653 cell line (Ventrex, Portland, ME) is most preferred. Once fused, the resulting hybridomas are cultured in a selective growth medium for one to two weeks. Two well known selection systems are available for eliminating unfused myeloma cells, or fusions between myeloma cells, from the mixed hybridoma culture. The choice of selection system depends on the strain of mouse immunized and myeloma fusion partner used. The AAT selection system, described by Taggart and Samloff, (1983), may be used; however, the HAT (hypoxanthine, aminopterin, thymidine) selection system, described by Littlefield, (1964), is preferred because of its compatibility with the preferred mouse strain and fusion partner mentioned above. Spent growth medium is then screened for immunospecific MAb secretion. Enzyme linked immunosorbent assay (ELISA) procedures are best suited for this purpose; though, radioimmunoassays adapted for large volume screening are also acceptable. Multiple screens designed to consecutively pare down the considerable number of irrelevant or less desired cultures may be performed. Cultures that secrete MAbs reactive with the B.t. insecticidal toxin may be screened for cross-reactivity with known B.t. insecticidal toxins. MAbs that preferentially bind to the preferred B.t. insecticidal toxin may be isotyped using commercially available assays. Preferred MAbs are of the IgG class, and more highly preferred MAbs are of the IgG1 and IgG 2 a subisotypes. [0089] Hybridoma cultures that secrete the preferred MAbs may be sub-cloned several times to establish monoclonality and stability. Well known methods for sub-cloning eukaryotic, non-adherent cell cultures include limiting dilution, soft agarose and fluorescence activated cell sorting techniques. After each subcloning, the resultant cultures preferably are be re-assayed for antibody secretion and isotype to ensure that a stable preferred MAb secreting culture has been established. [0090] The anti-B.t. toxin antibodies are useful in various methods of detecting the claimed B.t. insecticidal toxin of the instant invention, and variants or fragments thereof. It is well known that antibodies labeled with a reporting group can be used to identify the 26 WO 2010/147879 PCT/US2010/038482 presence of antigens in a variety of milieus. Antibodies labeled with radioisotopes have been used for decades in radioimmunoassays to identify, with great precision and sensitivity, the presence of antigens in a variety of biological fluids. More recently, enzyme labeled antibodies have been used as a substitute for radiolabeled antibodies in the ELISA assay. Further, antibodies immunoreactive to the B.t. insecticidal toxin of the present invention can be bound to an immobilizing substance such as a polystyrene well or particle and used in immunoassays to determine whether the B.t. toxin is present in a test sample. Detection using probes [0091] A further method for identifying the toxins and genes of the subject invention is through the use of oligonucleotide probes. These probes are detectable nucleotide sequences. These sequences may be rendered detectable by virtue of an appropriate radioactive label or may be made inherently fluorescent as described in US Patent No. 6268132. As is well known in the art, if the probe molecule and nucleic acid sample hybridize by forming strong base-pairing bonds between the two molecules, it can be reasonably assumed that the probe and sample have substantial sequence homology. Preferably, hybridization is conducted under stringent conditions by techniques well-known in the art, as described, for example, in Keller and Manak (1993). Detection of the probe provides a means for determining in a known manner whether hybridization has occurred. Such a probe analysis provides a rapid method for identifying toxin-encoding genes of the subject invention. The nucleotide segments which are used as probes according to the invention can be synthesized using a DNA synthesizer and standard procedures. These nucleotide sequences can also be used as PCR primers to amplify genes of the subject invention. Hybridization [0092] As is well known to those skilled in molecular biology, similarity of two nucleic acids can be characterized by their tendency to hybridize. As used herein the terms "stringent conditions" or "stringent hybridization conditions" are intended to refer to conditions under which a probe will hybridize (anneal) to its target sequence to a detectably greater degree than to other sequences (e.g. at least 2-fold over background). Stringent conditions are sequence dependent and will be different in different circumstances. By controlling the stringency of the hybridization and/or washing conditions, target sequences that are 100% complementary to the probe can be identified (homologous probing). Alternatively, stringency conditions can be adjusted to allow some mismatching in sequences so that lower degrees of similarity are 27 WO 2010/147879 PCT/US2010/038482 detected (heterologous probing). Generally, a probe is less than about 1000 nucleotides in length, preferably less than 500 nucleotides in length. [0093] Typically, stringent conditions will be those in which the salt concentration is less than about 1.5 M Na ion, typically about 0.01 to 1.0 M Na ion concentration (or other salts) at pH 7.0 to pH 8.3 and the temperature is at least about 30'C for short probes (e.g. 10 to 50 nucleotides) and at least about 60'C for long probes (e.g. greater than 50 nucleotides). Stringent conditions may also be achieved with the addition of destabilizing agents such as formamide. Exemplary low stringency conditions include hybridization with a buffer solution of 30% to 35% formamide, 1 M NaCl, 1% SDS (sodium dodecyl sulfate) at 37'C and a wash in 1X to 2X SSC (20X SSC = 3.0 M NaC1/0.3 M trisodium citrate) at 50'C to 55'C. Exemplary moderate stringency conditions include hybridization in 40% to 45% formamide, 1.0 M NaCl, 1% SDS at 37'C and a wash in 0.5X to IX SSC at 55 0 C to 60'C. Exemplary high stringency conditions include hybridization in 50% formamide, 1 M NaCl, 1% SDS at 37'C and a wash in 0.1X SSC at 60'C to 65'C. Optionally, wash buffers may comprise about 0.1% to about 1% SDS. Duration of hybridization is generally less than about 24 hours, usually about 4 to about 12 hours. [0094] Specificity is typically the function of post-hybridization washes, the critical factors being the ionic strength and temperature of the final wash solution. For DNA/DNA hybrids, the thermal melting point (Tm) is the temperature (under defined ionic strength and pH) at which 50% of a complementary target sequence hybridizes to a perfectly matched probe. Tm is reduced by about 1C for each 1% of mismatching; thus, Tm, hybridization conditions, and/or wash conditions can be adjusted to facilitate annealing of sequences of the desired identity. For example, if sequences with >90% identity are sought, the Tm can be decreased 10'C. Generally, stringent conditions are selected to be about 5'C lower than the Tm for the specific sequence and its complement at a defined ionic strength and pH. However, highly stringent conditions can utilize a hybridization and/or wash at 1C, 2'C, 3C, or 4'C lower than the Tm; moderately stringent conditions can utilize a hybridization and/or wash at 6'C, 7'C, 8'C, 9'C, or 10'C lower than the Tm, and low stringency conditions can utilize a hybridization and/or wash at 11 C, 12'C, 13'C, 14C, 15'C, or 20'C lower than the Tm. 28 WO 2010/147879 PCT/US2010/038482 [0095] Tm (in C) may be experimentally determined or may be approximated by calculation. For DNA-DNA hybrids, the Tm can be approximated from the equation of Meinkoth and Wahl (1984): Tm( 0 C) = 81.5'C + 16.6(log M) + 0.41(%GC) - 0.61(% formamide) - 500/L; where M is the molarity of monovalent cations, %GC is the percentage of guanosine and cytosine nucleotides in the DNA, % formamide is the percentage of formamide in the hybridization solution, and L is the length of the hybrid in base pairs [0096] Alternatively, the Tm is described by the following formula (Beltz et al., 1983). Tm( 0 C) = 81.5'C + 16.6(log[Na+]) + 0.41(%GC) - 0.61(% formamide) 600/L where [Na+] is the molarity of sodium ions, %GC is the percentage of guanosine and cytosine nucleotides in the DNA, % formamide is the percentage of formamide in the hybridization solution, and L is the length of the hybrid in base pairs [0097] Using the equations, hybridization and wash compositions, and desired Tm, those of ordinary skill will understand that variations in the stringency of hybridization and/or wash solutions are inherently described. If the desired degree of mismatching results in a Tm of less than 45'C (aqueous solution) or 32'C (formamide solution), it is preferred to increase the SSC concentration so that a higher temperature can be used. An extensive guide to the hybridization of nucleic acids is found in Tijssen (1993) and Ausubel et al., 1995) Also see Sambrook et al., (1989). [0098] Hybridization of immobilized DNA on Southern blots with radioactively labeled gene-specific probes may be performed by standard methods Sambrook et al., supra.). Radioactive isotopes used for labeling polynucleotide probes may include 32P, 33P, 14C, or 3H. Incorporation of radioactive isotopes into polynucleotide probe molecules may be done by any of several methods well known to those skilled in the field of molecular biology. (See, e.g. Sambrook et al., supra.) In general, hybridization and subsequent washes may be carried out under stringent conditions that allow for detection of target sequences with homology to the claimed toxin encoding genes. For double-stranded DNA gene probes, hybridization may be carried out overnight at 20-25'C below the Tm of the DNA hybrid in 6X SSPE, 5X Denhardt's Solution, 0.1% SDS, 0.1 mg/mL denatured DNA [20X SSPE is 3M NaCl, 0.2 M NaHPO 4 , and 0.02M EDTA (ethylenediamine tetra-acetic acid sodium salt); 1OOX Denhardt's 29 WO 2010/147879 PCT/US2010/038482 Solution is 20 gm/L Polyvinylpyrollidone, 20 gm/L Ficoll type 400 and 20 gm/L Bovine Serum Albumin (fraction V)]. [0099] Washes may typically be carried out as follows: Twice at room temperature for 15 minutes in IX SSPE, 0.1% SDS (low stringency wash). Once at Tm - 20'C for 15 minutes in 0.2X SSPE, 0.1% SDS (moderate stringency wash). [00100] For oligonucleotide probes, hybridization may be carried out overnight at 10-20'C below the Tm of the hybrid in 6X SSPE, 5X Denhardt's solution, 0.1% SDS, 0.1 mg/mL denatured DNA. Tm for oligonucleotide probes may be determined by the following formula (Suggs et al., 1981). Tm( 0 C ) = 2(number of T/A base pairs) + 4(number of G/C base pairs) [00101] Washes may typically be carried out as follows: Twice at room temperature for 15 minutes IX SSPE, 0.1% SDS (low stringency wash). Once at the hybridization temperature for 15 minutes in IX SSPE, 0.1% SDS (moderate stringency wash). [00102] Probe molecules for hybridization and hybrid molecules formed between probe and target molecules may be rendered detectable by means other than radioactive labeling. Such alternate methods are intended to be within the scope of this invention. [00103] It should be understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and the scope of the appended claims EXAMPLE 1 Isolation of a gene encoding DIG-10 toxin [00104] Nucleic acid encoding the insecticidal Cry protein designated herein as DIG-10 was isolated from B. t. strain PS 1 84M 1. Degenerate primers to be used as Forward and Reverse primers in PCR reactions using PS184M1 genomic DNA as template were designed based on multiple sequence alignments of each class of B.t. insecticidal toxin. The Forward Primer corresponds to bases 709 to 733 of SEQ ID NO:1, and the Reverse Primer corresponds to the complement of bases 2128 to 2141 of SEQ ID NO:1. This pair of primers 30 WO 2010/147879 PCT/US2010/038482 was used to amplify a fragment of 1443 bp, corresponding to nucleotides 709 to 2141 of SEQ ID NO: 1. This sequence was used as the anchor point to begin genome walking using methods adapted from the GenomeWalkerTM Universal Kit (Clontech, Palo Alto, CA). The nucleic acid sequence of a fragment spanning the DIG-10 coding region was determined. SEQ ID NO:1 is the 3393 bp nucleotide sequence encoding the full length DIG-10 protein. SEQ ID NO:2 is the amino acid sequence of the full length DIG-10 protein deduced from SEQ ID NO:1. EXAMPLE 2 Deletion of Domain I a-helices from DIG-10 [00105] To improve the insecticidal properties of the DIG-10 toxin, serial, step-wise deletions are made, each of which removes part of the N-terminus of the DIG-10 protein. The deletions remove part or all of a-helix 1 and part or all of a-helix 2 in Domain I, while maintaining the structural integrity of a-helix 3 through a-helix 7. [00106] Deletions are designed as follows. This example utilizes the full length chimeric DNA sequence encoding the full-length DIG-10 protein e.g. SEQ ID NO:1 and SEQ ID NO:2, respectively) to illustrate the design principles with 71 specific variants. It utilizes the chimeric sequence of SEQ ID NO:5 (DNA encoding DIG-10 core toxin fused to CrylAb protoxin segment) to provide an additional 71 specific variants. One skilled in the art will realize that other DNA sequences encoding all or an N-terminal portion of the DIG-10 protein may be similarly manipulated to achieve the desired result. To devise the first deleted variant coding sequence, all of the bases that encode a-helix 1 including the codon for the proline residue near the beginning of a-helix 2A (i.e. P53 for the full length DIG-10 protein of SEQ ID NO:2), are removed. Thus, elimination of bases 1 through 159 of SEQ ID NO:1 removes the coding sequence for amino acids 1 through 53 of SEQ ID NO:2. Reintroduction of a translation initiating ATG (methionine) codon at the beginning (i.e. in front of the codon corresponding to amino acid 54 of the full length protein) provides for the deleted variant coding sequence comprising an open reading frame of 3237 bases which encodes a deleted variant DIG-10 protein comprising 1079 amino acids (i.e. methionine plus amino acids 54 to 1131 of the full-length DIG-10 protein). Serial, stepwise deletions that remove additional codons for a single amino acid corresponding to residues 54 through 96 of the full-length DIG-10 protein of SEQ ID NO:2 provide variants missing part or all of a-helix 2A and ax 31 WO 2010/147879 PCT/US2010/038482 helix 2B. Thus a second designed deleted variant coding sequence requires elimination of bases I to 162 of SEQ ID NO:1, thereby removing the coding sequence for amino acids 1 through 54. Restoration of a functional open reading frame is again accomplished by reintroduction of a translation initiation methionine codon at the beginning of the remaining coding sequence, thus providing for a second deleted variant coding sequence having an open reading frame of 3234 bases encoding a deleted variant DIG-10 protein comprising 1078 amino acids (i.e. methionine plus amino acids 55 through 1131 of the full-length DIG-10 protein). The last designed deleted variant coding sequence requires removal of bases 1 through 288 of SEQ ID NO:1, thus eliminating the coding sequence for amino acids 1 through 96, and, after reintroduction of a translation initiation methionine codon, providing a deletion variant coding sequence having an open reading frame of 3108 bases which encodes a deletion variant DIG-10 protein of 1036 amino acids (i.e. methionine plus amino acids 97 through 1131 of the full-length DIG-10 protein). As exemplified, after elimination of the deletion sequence, an initiator methionine codon is added to the beginning of the remaining coding sequence to restore a functional open reading frame. Also as described, an additional glycine codon is to be added between the methionine codon and the codon for the instability determining amino acid in the instance that removal of the deleted sequence leaves exposed at the N-terminus of the remaining portion of the full-length protein one of the instability determining amino acids as provided above. [00107] Table 3 describes specific variants designed in accordance with the strategy described above. Table 3. Deletion variant protein sequences of the full-length DIG-10 protein of SEQ ID NO:2 and the fusion protein sequence of SEQ ID NO:5. DIG-10 Residues Residues of DIG-10 Residues Residues of Deletion added at SEQ ID NO:2 Deletion added at SEQ ID NO:5 Variant NH2 terminus Variant NH2 terminus 1 M 54-1131 72 M 54-1176 2 M 55-1131 73 M 55-1176 3 M 56-1131 74 M 56-1176 4 M 57-1131 75 M 57-1176 5 M 58-1131 76 M 58-1176 6 M 59-1131 77 M 59-1176 7 M 60-1131 78 M 60-1176 8 MG 60-1131 79 MG 60-1176 9 M 61-1131 80 M 61-1176 10 MG 61-1131 81 MG 61-1176 11 M 62-1131 82 M 62-1176 32 WO 2010/147879 PCT/US2010/038482 DIG-10 Residues Residues of DIG-10 Residues Residues of Deletion added at SEQ ID NO:2 Deletion added at SEQ ID NO:5 Variant NH2 terminus Variant NH2 terminus 12 MG 62-1131 83 MG 62-1176 13 M 63-1131 84 M 63-1176 14 MG 63-1131 85 MG 63-1176 15 M 64-1131 86 M 64-1176 16 MG 64-1131 87 MG 64-1176 17 M 65-1131 88 M 65-1176 18 MG 65-1131 89 MG 65-1176 19 M 66-1131 90 M 66-1176 20 MG 66-1131 91 MG 66-1176 21 M 67-1131 92 M 67-1176 22 MG 67-1131 93 MG 67-1176 23 M 68-1131 94 M 68-1176 24 MG 68-1131 95 MG 68-1176 25 M 69-1131 96 M 69-1176 26 MG 69-1131 97 MG 69-1176 27 M 70-1131 98 M 70-1176 28 MG 70-1131 99 MG 70-1176 29 M 71-1131 100 M 71-1176 30 MG 71-1131 101 MG 71-1176 31 M 72-1131 102 M 72-1176 32 MG 72-1131 103 MG 72-1176 33 M 73-1131 104 M 73-1176 34 MG 73-1131 105 MG 73-1176 35 M 74-1131 106 M 74-1176 36 M 75-1131 107 M 75-1176 37 MG 75-1131 108 MG 75-1176 38 M 76-1131 109 M 76-1176 39 M 77-1131 110 M 77-1176 40 M 78-1131 111 M 78-1176 41 MG 78-1131 112 MG 78-1176 42 M 79-1131 113 M 79-1176 43 M 80-1131 114 M 80-1176 44 M 81-1131 115 M 81-1176 45 MG 81-1131 116 MG 81-1176 46 M 82-1131 117 M 82-1176 47 M 83-1131 118 M 83-1176 48 M 84-1131 119 M 84-1176 49 MG 84-1131 120 MG 84-1176 50 M 85-1131 121 M 85-1176 51 M 86-1131 122 M 86-1176 52 M 87-1131 123 M 87-1176 53 MG 87-1131 124 MG 87-1176 54 M 88-1131 125 M 88-1176 33 WO 2010/147879 PCT/US2010/038482 DIG-10 Residues Residues of DIG-10 Residues Residues of Deletion added at SEQ ID NO:2 Deletion added at SEQ ID NO:5 Variant NH2 terminus Variant NH2 terminus 55 MG 88-1131 126 MG 88-1176 56 M 89-1131 127 M 89-1176 57 MG 89-1131 128 MG 89-1176 58 M 90-1131 129 M 90-1176 59 MG 90-1131 130 MG 90-1176 60 M 91-1131 131 M 91-1176 61 MG 91-1131 132 MG 91-1176 62 M 92-1131 133 M 92-1176 63 M 93-1131 134 M 93-1176 64 MG 93-1131 135 MG 93-1176 65 M 94-1131 136 M 94-1176 66 M 95-1356 137 M 95-1176 67 MG 95-1131 138 MG 95-1176 68 M 96-1131 139 M 96-1176 69 MG 96-1131 140 MG 96-1176 70 M 97-1131 141 M 97-1176 71 MG 97-1131 142 MG 97-1176 [00108] Nucleic acids encoding the toxins described in Table 3 are designed in accordance with the general principles for synthetic genes intended for expression in plants, as discussed above. EXAMPLE 3 Design of a plant-optimized version of the coding sequence for the DIG-10 B.t. insecticidal protein [00109] A DNA sequence having a plant codon bias was designed and synthesized to produce the DIG-10 protein in transgenic monocot and dicot plants. A codon usage table for maize (Zea mays L.) was calculated from 706 protein coding sequences (CDs) obtained from sequences deposited in GenBank. Codon usage tables for tobacco (Nicotiana tabacum, 1268 CDs), canola (Brassica napus, 530 CDs), cotton (Gossypium hirsutum, 197 CDs), and soybean (Glycine max; ca. 1000 CDs) were downloaded from data at the website http://www.kazusa.or.jp/codon/. A biased codon set that comprises highly used codons common to both maize and dicot datasets, in appropriate weighted average relative amounts, was calculated after omitting any redundant codon used less than about 10% of total codon uses for that amino acid in either plant type. To derive a plant optimized sequence encoding the DIG-10 protein, codon substitutions to the experimentally determined DIG-10 DNA 34 WO 2010/147879 PCT/US2010/038482 sequence were made such that the resulting DNA sequence had the overall codon composition of the plant-optimized codon bias table. Further refinements of the sequence were made to eliminate undesirable restriction enzyme recognition sites, potential plant intron splice sites, long runs of A/T or C/G residues, and other motifs that might interfere with RNA stability, transcription, or translation of the coding region in plant cells. Other changes were made to introduce desired restriction enzyme recognition sites, and to eliminate long internal Open Reading Frames (frames other than +1). These changes were all made within the constraints of retaining the plant-biased codon composition. Synthesis of the designed sequence was performed by a commercial vendor (DNA2.0, Menlo Park, CA). [00110] Additional guidance regarding the production of synthetic genes can be found in, for example, WO 97/13402 and US Patent No. 5380831. [00111] A maize-optimized DNA sequence encoding the DIG-10 core toxin is given in SEQ ID NO:3. A dicot-optimized DNA sequence encoding the CrylAb protoxin segment is disclosed as SEQ ID NO:6. A maize- optimized DNA sequence encoding the CrylAb protoxin segment is disclosed as SEQ ID NO:7. EXAMPLE 4 Construction of expression plasmids encoding DIG-10 insecticidal toxin and expression in bacterial hosts [00112] Standard cloning methods are used in the construction of Pseudomonas fluorescens (Pf) expression plasmids engineered to produce full-length DIG-10 proteins encoded by plant-optimized coding regions. Restriction endonucleases arre obtained from New England BioLabs (NEB; Ipswich, MA) and T4 DNA Ligase (Invitrogen) is used for DNA ligation. Plasmid preparations are performed using the NucleoBond@ Xtra Kit (Macherey-Nagel Inc, Bethlehem, PA) or the Plasmid Midi Kit (Qiagen), following the instructions of the suppliers. DNA fragments are purified using the Millipore Ultrafree@-DA cartridge (Billerica, MA) after agarose Tris-acetate gel electrophoresis. [00113] The basic cloning strategy entails subcloning the DIG-10 toxin coding sequence (CDS) into pDOW1 169 at. for example, SpeI and XhoI restriction sites, whereby it is placed under the expression control of the Ptac promoter and the rrnBT1T2 terminator from plasmid pKK223-3 (PL Pharmacia, Milwaukee, WI). pDOW1 169 is a medium copy plasmid with the RSF1010 origin of replication, a pyrF gene, and a ribosome binding site preceding the restriction enzyme recognition sites into which DNA fragments containing protein coding 35 WO 2010/147879 PCT/US2010/038482 regions may be introduced, (US Patent Application No. 20080193974). The expression plasmid is transformed by electroporation into DC454 (a near wild-type P. fluorescens strain having mutations ApyrF and 1sc::lacIQ'), or its derivatives, recovered in SOC-Soy hydrolysate medium, and plated on selective medium (M9 glucose agar lacking uracil, Sambrook et al., supra). Details of the microbiological manipulations are available in Squires et al., (2004), US Patent Application No. 20060008877, US Patent Application No. 20080193974, and US Patent Application No. 20080058262, incorporated herein by reference. Colonies are first screened by PCR and positive clones are then analyzed by restriction digestion of miniprep plasmid DNA. Plasmid DNA of selected clones containing inserts is sequenced, either by using Big Dye@ Terminator version 3.1 as recommended by the suppler (Applied Biosystems/Invitrogen), or by contract with a commercial sequencing vendor such as MWG Biotech (Huntsville, AL). Sequence data is assembled and analyzed using the SequencherTM software (Gene Codes Corp., Ann Arbor, MI). [00114] Growth and Expression Analysis in Shake Flasks Production of DIG-10 toxin for characterization and insect bioassay is accomplished by shake-flask-grown P. fluorescens strains harboring expression constructs (e.g. clone DP2826). Seed cultures grown in M9 medium supplemented with 1% glucose and trace elements are used to inoculate 50 mL of defined minimal medium with 5% glycerol (Teknova Cat. # 3D7426, Hollister, CA). Expression of the DIG-10 toxin gene via the Ptac promoter is induced by addition of isopropyl- 3-D-1-thiogalactopyranoside (IPTG) after an initial incubation of 24 hours at 30'C with shaking. Cultures are sampled at the time of induction and at various times post induction. Cell density is measured by optical density at 600 nm (OD 600 ). Other culture media suitable for growth of Pseudomonasfluorescens may also be utilized, for example, as described in Huang et al., 2007 and US Patent Application No. 20060008877. [00115] Cell Fractionation and SDS-PAGE Analysis of Shake Flask Samples At each sampling time, the cell density of samples is adjusted to OD 6 00 = 20 and 1 mL aliquots are centrifuged at 14000 x g for five minutes. The cell pellets are frozen at -80'C. Soluble and insoluble fractions from frozen shake flask cell pellet samples are generated using EasyLyse T M Bacterial Protein Extraction Solution (EPICENTRE@ Biotechnologies, Madison, WI). Each cell pellet is resuspended in 1 mL EasyLyse T M solution and further diluted 1:4 in lysis buffer and incubated with shaking at room temperature for 30 minutes. The lysate is centrifuged at 14,000 rpm for 20 minutes at 4'C and the supernatant is recovered as the 36 WO 2010/147879 PCT/US2010/038482 soluble fraction. The pellet (insoluble fraction) is then resuspended in an equal volume of phosphate buffered saline (PBS; 11.9 mM Na 2
HPO
4 , 137 mM NaCl, 2.7 mM KCl, pH7.4). [00116] Samples are mixed 1:1 with 2X Laemmli sample buffer containing 0 mercaptoethanol (Sambrook et al., supra.) and boiled for 5 minutes prior to loading onto Criterion XT Bis-Tris 12% gels (Bio-Rad Inc., Hercules, CA.) Electrophoresis is performed in the recommended XT MOPS buffer. Gels are stained with Bio-Safe Coomassie Stain according to the manufacturer's (Bio-Rad) protocol and imaged using the Alpha Innotech Imaging system (San Leandro, CA). [00117] Inclusion body preparation Cry protein inclusion body (IB) preparations are performed on cells from P. fluorescens fermentations that produced insoluble B.t. insecticidal protein, as demonstrated by SDS-PAGE and MALDI-MS (Matrix Assisted Laser Desorption/Ionization Mass Spectrometry). P. fluorescens fermentation pellets are thawed in a 37 0 C water bath. The cells are resuspended to 25% w/v in lysis buffer (50 mM Tris, pH 7.5, 200 mM NaCl, 20 mM EDTA disodium salt (Ethylenediaminetetraacetic acid), 1% Triton X 100, and 5 mM Dithiothreitol (DTT); 5 mL/L of bacterial protease inhibitor cocktail (P8465 Sigma-Aldrich, St. Louis,. MO) are added just prior to use). The cells are suspended using a hand-held homogenizer at lowest setting (Tissue Tearor, BioSpec Products, Inc., Bartlesville, OK). Lysozyme (25 mg of Sigma L7651, from chicken egg white) is added to the cell suspension by mixing with a metal spatula, and the suspension is incubated at room temperature for one hour. The suspension is cooled on ice for 15 minutes, then sonicated using a Branson Sonifier 250 (two 1- minute sessions, at 50% duty cycle, 30% output). Cell lysis is checked by microscopy. An additional 25 mg of lysozyme are added if necessary, and the incubation and sonication are repeated. When cell lysis is confirmed via microscopy, the lysate is centrifuged at 11,500 x g for 25 minutes (4'C) to form the IB pellet, and the supernatant is discarded. The IB pellet is resuspended with 100 mL lysis buffer, homogenized with the hand-held mixer and centrifuged as above. The IB pellet is repeatedly washed by resuspension (in 50 mL lysis buffer), homogenization, sonication, and centrifugation until the supernatant becomes colorless and the IB pellet becomes firm and off white in color. For the final wash, the 1B pellet is resuspended in sterile-filtered (0.22 pm) distilled water containing 2 mM EDTA, and centrifuged. The final pellet iss resuspended in sterile-filtered distilled water containing 2 mM EDTA, and stored in 1 mL aliquots at -80'C. 37 WO 2010/147879 PCT/US2010/038482 [00118] SDS-PAGE analysis and quantitation of protein in IB preparations are done by thawing a 1 mL aliquot of IB pellet and diluting 1:20 with sterile-filtered distilled water. The diluted sample is then boiled with 4X reducing sample buffer [250 mM Tris, pH6.8, 40% glycerol (v/v), 0.4% Bromophenol Blue (w/v), 8% SDS (w/v) and 8% P-Mercapto-ethanol (v/v)] and loaded onto a Novex@ 4-20% Tris-Glycine, 12+2 well gel (Invitrogen) run with IX Tris/Glycine/SDS buffer (BioRad). The gel is run for approximately 60 min at 200 volts then stained with Coomassie Blue (50% G-250/50% R-250 in 45% methanol, 10% acetic acid), and destained with 7% acetic acid, 5% methanol in distilled water. Quantification of target bands is done by comparing densitometric values for the bands against Bovine Serum Albumin (BSA) samples run on the same gel to generate a standard curve. [00119] Solubilization of Inclusion Bodies Six mL of inclusion body suspension from Pf clone DP2826 (containing 32 mg/mL of DIG-10 protein) are centrifuged on the highest setting of an Eppendorf model 5415C microfuge (approximately 14,000 x g) to pellet the inclusions. The storage buffer supernatant is removed and replaced with 25 mL of 100 mM sodium carbonate buffer, pHi 1, in a 50 mL conical tube. Inclusions are resuspended using a pipette and vortexed to mix thoroughly. The tube is placed on a gently rocking platform at 4'C overnight to extract the target protein. The extract is centrifuged at 30,000 x g for 30 min at 4'C, and the resulting supernatant is concentrated 5-fold using an Amicon Ultra-15 regenerated cellulose centrifugal filter device (30,000 Molecular Weight Cutoff; Millipore). The sample buffer is then changed to 10 mM CAPS [3-(cyclohexamino)1-propanesulfonic acid] pH 10, using disposable PD-10 columns (GE Healthcare, Piscataway, NJ). [00120] Gel electrophoresis The concentrated extract is prepared for electrophoresis by diluting 1:50 in NuPAGE@ LDS sample buffer (Invitrogen) containing 5 mM dithiothreitol as a reducing agent and heated at 95'C for 4 minutes. The sample is loaded in duplicate lanes of a 4-12% NuPAGE@ gel alongside five BSA standards ranging from 0.2 to 2 Vg/lane (for standard curve generation). Voltage is applied at 200V using MOPS SDS running buffer (Invitrogen) until the tracking dye reached the bottom of the gel. The gel is stained with 0.2% Coomassie Blue G-250 in 45% methanol, 10% acetic acid, and destained, first briefly with 45% methanol, 10% acetic acid, and then at length with 7% acetic acid, 5% methanol until the background clears. Following destaining, the gel is scanned with a Biorad Fluor-S Multilmager. The instrument's Quantity One v.4.5.2 Software is used to obtain background 38 WO 2010/147879 PCT/US2010/038482 subtracted volumes of the stained protein bands and to generate the BSA standard curve that is used to calculate the concentration of DIG-10 protein in the stock solution. EXAMPLE 5 Insecticidal activity of modified DIG-10 protein produced in Pseudomonas fluorescens [00121] DIG-10 B.t. insecticidal toxin is tested for activity on larvae of Colepteran insects, including, for example, western corn rootworm (WCR, Diabrotica virgifera virgifera LeConte), southern corn rootworm (SCR, Diabrotica undecimpunctata howardi). DIG-10 B.t. insecticidal toxin is further tested for activity on larvae of Lepidopteran insects, including, for example,corn earworm (CEW; Helicoverpa zea (Boddie)), European corn borer (ECB; Ostrinia nubilalis (HUbner)), cry1F-resistant ECB (rECB), fall armyworm (FAW, Spodopterafrugiperda), Cry1F-resistant FAW (rFAW), diamondback moth (DBM; Plutella xylostella (Linnaeus)), crylA-resistant DBM (rDBM), tobacco budworm (TBW; Heliothis virescens (Fabricius)), black cutworm (BCW; Agrotis ipsilon (Hufnagel)), cabbage looper (CL; Trichoplusia ni (HUbner)), and beet armyworm (BAW, Spodoptera exigua, beet armyworm). [00122] Sample preparation and bioassays Inclusion body preparations in 10 mM CAPS pH10 are diluted appropriately in 10 mM CAPS pH 10, and all bioassays contain a control treatment consisting of this buffer, which serves as a background check for mortality or growth inhibition. [00123] Protein concentrations in bioassay buffer are estimated by gel electrophoresis using BSA to create a standard curve for gel densitometry, which is measured using a BioRad imaging system (Fluor-S Multilmager with Quantity One software version 4.5.2). Proteins in the gel matrix are stained with Coomassie Blue-based stain and destained before reading. [00124] Purified proteins are tested for insecticidal activity in bioassays conducted with neonateinsect larvae on artificial insect diet. Larvae of, for example, BCW, CEW, CL, DBM, rDBM, ECB, FAW and TBW are hatched from eggs obtained from a colony maintained by a commercial insectary (Benzon Research Inc., Carlisle, PA). WCR and SCR eggs are obtained from Crop Characteristics, Inc. (Farmington, MN). Larvae of rECB and rFAW are hatched from eggs harvested from proprietary colonies (Dow AgroSciences LLC, Indianapolis, IN). [00125] The bioassays are conducted in 128-well plastic trays specifically designed for insect bioassays (C-D International, Pitman, NJ). Each well contains 1.0 mL of Multi-species 39 WO 2010/147879 PCT/US2010/038482 Lepidoptera diet (Southland Products, Lake Village, AR) or a proprietary diet designed for growth of Coleopteran insects (Dow AgroSciences LLC, Indianapolis, IN). A 40 VL aliquot of protein sample is delivered by pipette onto the 1.5 cm 2 diet surface of each well (26.7 iL/cm 2 ). Diet concentrations are calculated as the amount (ng) of DIG-10 protein per square centimeter (cm 2 ) of surface area in the well. The treated trays are held in a fume hood until the liquid on the diet surface has evaporated or is absorbed into the diet. [00126] Within a few hours of eclosion, individual larvae are picked up with a moistened camel hair brush and deposited on the treated diet, one larva per well. The infested wells are then sealed with adhesive sheets of clear plastic, vented to allow gas exchange (C-D International, Pitman, NJ). Bioassay trays are held under controlled environmental conditions (28 C, -40% Relative Humidity, 16:8 [Light:Dark]) for 5 days, after which the total number of insects exposed to each protein sample, the number of dead insects, and the weight of surviving insects are recorded. Percent mortality and percent growth inhibition are calculated for each treatment. Growth inhibition (GI) is calculated as follows: GI= [1 - (TWIT/TNIT)/(TWIBC/TNIBC)] where TWIT is the Total Weight of Insects in the Treatment, TNIT is the Total Number of Insects in the Treatment TWIBC is the Total Weight of Insects in the Background Check (Buffer control), and TNIBC is the Total Number of Insects in the Background Check (Buffer control). [00127] The G1 50 is determined to be the concentration of DIG-10 protein in the diet at which the GI value is 50%. The LC 5 0 (50% Lethal Concentration) is recorded as the concentration of DIG-10 protein in the diet at which 50% of test insects are killed. Statistical analysis (One-way ANOVA) is done using JMP software (SAS, Cary, NC) EXAMPLE 6 Agrobacterium transformation [00128] Standard cloning methods are used in the construction of binary plant transformation and expression plasmids. Restriction endonucleases and T4 DNA Ligase are obtained from NEB. Plasmid preparations are performed using the NucleoSpin@ Plasmid Preparation kit or the NucleoBond@ AX Xtra Midi kit (both from Macherey-Nagel), following the instructions of the manufacturers. DNA fragments are purified using the QlAquick PCR Purification Kit or the QIAEX II Gel Extraction Kit (both from Qiagen) after gel isolation. 40 WO 2010/147879 PCT/US2010/038482 [00129] DNA fragments comprising the nucleotide sequences that encode the modified DIG-10 proteins, or fragments thereof, may be synthesized by a commercial vendor (e.g. DNA2.0, Menlo Park, CA) and supplied as cloned fragments in standard plasmid vectors, or may be obtained by standard molecular biology manipulation of other constructs containing appropriate nucleotide sequences. Unique restriction sites internal to each gene may be identified and a fragment of each gene synthesized, each containing a specific deletion or insertion. The modified Cry fragments may subcloned into other Cry fragments coding regions at a appropriate restriction sites to obtain a coding region encoding the desired full length protein, fused proteins, or deleted variant proteins. For example one may identify an appropriate restriction recognition site at the start of the gene and a second internal restriction site specific for each gene, which may be used to construct variant clones. [00130] In a non-limiting example, a basic cloning strategy may be to subclone full length or modified Cry coding sequences (CDS) into a plant expression plasmid at NcoI and SacI restriction sites. The resulting plant expression cassettes containing the appropriate Cry coding region under the control of plant expression elements, (e.g., plant expressible promoters, 3' terminal transcription termination and polyadenylate addition determinants, and the like) are subcloned into a binary vector plasmid, utilizing, for example, Gateway® technology or standard restriction enzyme fragment cloning procedures. LR ClonaseTM (Invitrogen) for example, may be used to recombine the full length and modified gene plant expression cassettes into a binary plant transformation plasmid if the Gateway technology is utilized. It is convenient to employ a binary plant transformation vector that harbors a bacterial gene that confers resistance to the antibiotic spectinomycin when the plasmid is present in E. coli and Agrobacterium cells. It is also convenient to employ a binary vector plasmid that contains a plant-expressible selectable marker gene that is functional in the desired host plants. Examples of plant-expressible selectable marker genes include but are not limited to the aminoglycoside phosphotransferase gene of transposon Tn5 (Aph II) which encodes resistance to the antibiotics kanamycin, neomycin and G418, as well as those genes which code for resistance or tolerance to glyphosate; hygromycin; methotrexate; phosphinothricin (bialaphos), imidazolinones, sulfonylureas and triazolopyrimidine herbicides, such as chlorosulfuron, bromoxynil, dalapon and the like. [00131] Electro-competent cells of Agrobacterium tumefaciens strain Z707S (a streptomycin-resistant derivative of Z707; Hepburn et al., 1985) are prepared and transformed 41 WO 2010/147879 PCT/US2010/038482 using electroporation (Weigel and Glazebrook, 2002). After electroporation, 1 mL of YEP broth (gm/L: yeast extract, 10; peptone, 10; NaCl, 5) are added to the cuvette and the cell YEP suspension is transferred to a 15 mL culture tube for incubation at 28'C in a water bath with constant agitation for 4 hours. The cells are plated on YEP plus agar (25 gm/L) with spectinomycin (200 pg/mL) and streptomycin (250 pg/mL) and the plates are incubated for 2 4 days at 28'C. Well separated single colonies are selected and streaked onto fresh YEP + agar plates with spectinomycin and streptomycin as before, and incubated at 28'C for 1-3 days. [00132] The presence of the DIG-10 gene insert in the binary plant transformation vector is performed by PCR analysis using vector-specific primers with template plasmid DNA prepared from selected Agrobacterium colonies. The cell pellet from a 4 mL aliquot of a 15 mL overnight culture grown in YEP with spectinomycin and streptomycin as before is extracted using Qiagen Spin Mini Preps, performed per manufacturer's instructions. Plasmid DNA from the binary vector used in the Agrobacterium electroporation transformation is included as a control. The PCR reaction is completed using Taq DNA polymerase from Invitrogen per manufacture's instructions at 0.5X concentrations. PCR reactions are carried out in a MJ Research Peltier Thermal Cycler programmed with the following conditions: Step 1) 94'C for 3 minutes; Step 2) 94'C for 45 seconds; Step 3) 55'C for 30 seconds; Step 4) 72'C for 1 minute per kb of expected product length; Step 5) 29 times to Step 2; Step 6) 72'C for 10 minutes. The reaction is maintained at 4'C after cycling. The amplification products are analyzed by agarose gel electrophoresis (e.g. 0.7 % to 1% agarose, w/v) and visualized by ethidium bromide staining. A colony is selected whose PCR product is identical to the plasmid control. [00133] Alternatively, the plasmid structure of the binary plant transformation vector containing the DIG-10 gene insert is performed by restriction digest fingerprint mapping of plasmid DNA prepared from candidate Agrobacterium isolates by standard molecular biology methods well known to those skilled in the art of Agrobacterium manipulation. [00134] Those skilled in the art of obtaining transformed plants via Agrobacterium mediated transformation methods will understand that other Agrobacterium strains besides Z707S may be used to advantage, and the choice of strain may depend upon the identity of the host plant species to be transformed. EXAMPLE 7 42 WO 2010/147879 PCT/US2010/038482 Production of DIG-10 B.t. insecticidal proteins and variants in dicot plants [00135] Arabidopsis Transformation Arabidopsis thaliana Col-01 is transformed using the floral dip method (Weigel and Glazebrook, 2002). The selected Agrobacterium colony is used to inoculate 1 mL to 15 mL cultures of YEP broth containing appropriate antibiotics for selection. The culture is incubated overnight at 28'C with constant agitation at 220 rpm. Each culture is used to inoculate two 500 mL cultures of YEP broth containing appropriate antibiotics for selection and the new cultures are incubated overnight at 28'C with constant agitation. The cells are pelleted at approximately 8700 x g for 10 minutes at room temperature, and the resulting supernatant is discarded. The cell pellet is gently resuspended in 500 mL of infiltration media containing: 1/2x Murashige and Skoog salts (Sigma Aldrich)/Gamborg's B5 vitamins (Gold BioTechnology, St. Louis, MO), 10% (w/v) sucrose, 0.044 VM benzylaminopurine (10 VL/liter of 1 mg/mL stock in DMSO) and 300 PL/liter Silwet L-77. Plants approximately 1 month old are dipped into the media for 15 seconds, with care taken to assure submergence of the newest inflorescence. The plants are then laid on their sides and covered (transparent or opaque) for 24 hours, washed with water, and placed upright. The plants are grown at 22'C, with a 16-hour light/8-hour dark photoperiod. Approximately 4 weeks after dipping, the seeds are harvested. [00136] Arabidopsis Growth and Selection Freshly harvested TI seed is allowed to dry for at least 7 days at room temperature in the presence of desiccant. Seed is suspended in a 0.1% agar/water (Sigma-Aldrich) solution and then stratified at 4'C for 2 days. To prepare for planting, Sunshine Mix LP5 (Sun Gro Horticulture Inc., Bellevue, WA) in 10.5 inch x 21 inch germination trays (T.O. Plastics Inc., Clearwater, MN) is covered with fine vermiculite, sub irrigated with Hoagland's solution (Hoagland and Arnon, 1950) until wet, then allowed to drain for 24 hours. Stratified seed is sown onto the vermiculite and covered with humidity domes (KORD Products, Bramalea, Ontario, Canada) for 7 days. Seeds are germinated and plants are grown in a Conviron (Models CMP4030 or CMP3244; Controlled Environments Limited, Winnipeg, Manitoba, Canada) under long day conditions (16 hours light/8 hours dark) at a light intensity of 120-150 Pmol/m 2 sec under constant temperature (22'C) and humidity (40-50%). Plants are initially watered with Hoagland's solution and subsequently with deionized water to keep the soil moist but not wet. [00137] The domes are removed 5-6 days post sowing and plants are sprayed with a chemical selection agent to kill plants germinated from nontransformed seeds. For example, 43 WO 2010/147879 PCT/US2010/038482 if the plant expressible selectable marker gene provided by the binary plant transformation vector is a pat or bar gene (Wehrmann et al., 1996), transformed plants may be selected by spraying with a 1000X solution of Finale (5.78% glufosinate ammonium, Farnam Companies Inc., Phoenix, AZ.). Two subsequent sprays are performed at 5-7 day intervals. Survivors (plants actively growing) are identified 7-10 days after the final spraying and transplanted into pots prepared with Sunshine Mix LP5. Transplanted plants are covered with a humidity dome for 3-4 days and placed in a Conviron under the above-mentioned growth conditions. [00138] Those skilled in the art of dicot plant transformation will understand that other methods of selection of transformed plants are available when other plant expressible selectable marker genes (e.g. herbicide tolerance genes) are used. [00139] Insect Bioassays of transgenic Arabidopsis Transgenic Arabidopsis lines expressing modified Cry proteins are demonstrated to be active against sensitive insect species in artificial diet overlay assays. Protein extracted from transgenic and non-transgenic Arabidopsis lines is quantified by appropriate methods and sample volumes are adjusted to normalize protein concentration. Bioassays are conducted on artificial diet as described above. Non-transgenic Arabidopsis and/or buffer and water are included in assays as background check treatments. EXAMPLE 8 Agrobacterium transformation for generation of superbinary vectors [00140] The Agrobacterium superbinary system is conveniently used for transformation of monocot plant hosts. Methodologies for constructing and validating superbinary vectors are well established. Standard molecular biological and microbiological methods are used to generate superbinary plasmids. Verification/validation of the structure of the superbinary plasmid is done using methodologies as described above for binary vectors. EXAMPLE 9 Production of DIG-10 B.t. insecticidal proteins and variants in monocot plants [00141] Agrobacterium-Mediated Transformation of Maize Seeds from a High II F 1 cross (Armstrong et al., 1991) are planted into 5-gallon-pots containing a mixture of 95% Metro Mix 360 soilless growing medium (Sun Gro Horticulture, Bellevue, WA) and 5% clay/loam soil. The plants are grown in a greenhouse using a combination of high pressure sodium and metal halide lamps with a 16:8 hour Light:Dark photoperiod. For obtaining immature F 2 44 WO 2010/147879 PCT/US2010/038482 embryos for transformation, controlled sib-pollinations are performed. Immature embryos are isolated at 8-10 days post-pollination when embryos are approximately 1.0 to 2.0 mm in size. [00142] Infection and co-cultivation. Maize ears are surface sterilized by scrubbing with liquid soap, immersing in 70% ethanol for 2 minutes, and then immersing in 20% commercial bleach (0.1% sodium hypochlorite) for 30 minutes before being rinsed with sterile water. A suspension Agrobacterium cells containing a superbinary vector is prepared by transferring 1 2 loops of bacteria grown on YEP solid medium containing 100 mg/L spectinomycin, 10 mg/L tetracycline, and 250 mg/L streptomycin at 28'C for 2-3 days into 5 mL of liquid infection medium (LS Basal Medium (Linsmaier and Skoog, 1965), N6 vitamins (Chu et al., 1975), 1.5 mg/L 2,4-Dichlorophenoxyacetic acid (2,4-D), 68.5 gm/L sucrose, 36.0 gm/L glucose, 6 mM L-proline, pH 5.2) containing 100 VM acetosyringone. The solution is vortexed until a uniform suspension is achieved, and the concentration is adjusted to a final density of 200 Klett units, using a Klett-Summerson colorimeter with a purple filter. Immature embryos are isolated directly into a micro centrifuge tube containing 2 mL of the infection medium. The medium is removed and replaced with 1 mL of the Agrobacterium solution with a density of 200 Klett units, and the Agrobacterium and embryo solution is incubated for 5 minutes at room temperature and then transferred to co-cultivation medium (LS Basal Medium, N6 vitamins, 1.5 mg/L 2,4-D, 30.0 gm/L sucrose, 6 mM L-proline, 0.85 mg/L AgNO 3 ,, 100 VM acetosyringone, 3.0 gm/L Gellan gum (PhytoTechnology Laboratories., Lenexa, KS), pH 5.8) for 5 days at 250 C under dark conditions. [00143] After co-cultivation, the embryos are transferred to selective medium after which transformed isolates are obtained over the course of approximately 8 weeks. For selection of maize tissues transformed with a superbinary plasmid containing a plant expressible pat or bar selectable marker gene, an LS based medium (LS Basal medium, N6 vitamins, 1.5 mg/L 2,4-D, 0.5 gm/L MES (2-(N-morpholino)ethanesulfonic acid monohydrate; PhytoTechnologies Labr.), 30.0 gm/L sucrose, 6 mM L-proline, 1.0 mg/L AgNO 3 , 250 mg/L cefotaxime, 2.5 gm/L Gellan gum, pH 5.7) is used with Bialaphos (Gold BioTechnology). The embryos are transferred to selection media containing 3 mg/L Bialaphos until embryogenic isolates are obtained. Recovered isolates are bulked up by transferring to fresh selection medium at 2-week intervals for regeneration and further analysis. [00144] Those skilled in the art of maize transformation will understand that other methods of selection of transformed plants are available when other plant expressible 45 WO 2010/147879 PCT/US2010/038482 selectable marker genes (e.g. herbicide tolerance genes) are used. [00145] Regeneration and seed production. For regeneration, the cultures are transferred to "28" induction medium (MS salts and vitamins, 30 gm/L sucrose, 5 mg/L Benzylaminopurine, 0.25 mg/L 2, 4-D, 3 mg/L Bialaphos, 250 mg/L cefotaxime, 2.5 gm/L Gellan gum, pH 5.7) for 1 week under low-light conditions (14 Em-2S- 1 ) then 1 week under high-light conditions (approximately 89 kEm- 2 s-1). Tissues are subsequently transferred to "36" regeneration medium (same as induction medium except lacking plant growth regulators). When plantlets grow to 3-5 cm in length, they are transferred to glass culture tubes containing SHGA medium (Schenk and Hildebrandt salts and vitamins (1972); PhytoTechnologies Labr.), 1.0 gm/L myo-inositol, 10 gm/L sucrose and 2.0 gm/L Gellan gum, pH 5.8) to allow for further growth and development of the shoot and roots. Plants are transplanted to the same soil mixture as described earlier herein and grown to flowering in the greenhouse. Controlled pollinations for seed production are conducted. EXAMPLE 10 Bioassay of transgenic maize [00146] Bioactivity of the DIG-10 protein and variants produced in plant cells is demonstrated by conventional bioassay methods (see, for example Huang et al., 2006). One is able to demonstrate efficacy, for example, by feeding various plant tissues or tissue pieces derived from a plant producing a DIG-10 toxin to target insects in a controlled feeding environment. Alternatively, protein extracts may be prepared from various plant tissues derived from a plant producing the DIG-10 toxin and incorporate the extracted proteins in an artificial diet bioassay as previously described herein. It is to be understood that the results of such feeding assays are to be compared to similarly conducted bioassays that employ appropriate control tissues from host plants that do not produce the DIG-10 protein or variants, or to other control samples. [00147] All patents, patent applications, provisional applications, and publications referred to or cited herein are incorporated by reference in their entirety to the extent they are not inconsistent with the explicit teachings of this specification. Unless specifically indicated or implied, the terms "a", "an", and "the" signify "at least one" as used herein. By the use of the term "genetic material" herein, it is meant to include all genes, nucleic acid, DNA and RNA. [00148] For designations of nucleotide residues of polynucleotides, DNA, RNA, oligonucleotides, and primers, and for designations of amino acid residues of proteins, 46 WO 2010/147879 PCT/US2010/038482 standard IUPAC abbreviations are employed throughout this document. Nucleic acid sequences are presented in the standard 5' to 3' direction, and protein sequences are presented in the standard amino (N) terminal to carboxy (C) terminal direction. The term "dsRNA" refers to double-stranded RNA. 47 WO 2010/147879 PCT/US2010/038482 References An, G., Watson, B. D., Stachel, S., Gordon, M. P., Nester, E. W. (1985) New cloning vehicles for transformation of higher plants. EMBO J. 4:277-284. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., Lipman, D. J. (1990) Basic local alignment search tool. J. Mol. Biol. 215:403-410. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W., Lipman, D. J. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl. Acids Res. 25:3389-3402. Armstrong, C. L., Green, C. E., Phillips, R. L. (1991) Development and availability of germplasm with high Typell culture formation response. Maize Genet. Coop. Newslett. 65:92-93. Aronson, A.I., Han, E.-S., McGaughey, W., Johnson, D. (1991) The solubility of inclusion proteins from Bacillus thuringiensis is dependent upon protoxin composition and is a factor in toxicity to insects. Appl. Environ. Microbiol. 57:981-986. Aronson, A. I., Geng, C., Wu. L. (1999) Aggregation of Bacillus thuringiensis CrylA toxins upon binding to target insect larval midgut vesicles. Appl. Environ. Microbiol. 65:2503 2507. Arvidson, H., Dunn, P. E., Strand, S., Aronson, A. I. (1989) Specificity of Bacillis thuringiensis for lepidopteran larvae: factors involved in vivo and in the structure of a purified toxin. Molec. Microbiol. 3:1533-1543. Ausubel et al., eds. (1995) Current Protocols in Molecular Biology, Chapter 2 (Greene Publishing and Wiley-Interscience, New York). Bailey, J. M., Shenov, N. R., Ronk, M., and Shively, J. E., (1992) Automated carboxy terminal sequence analysis of peptides. Protein Sci. 1:68-80. Beltz, G.A., Jacobs, K. A., Eickbush, T. H., Cherbas, P. T., Kafatos, F. C. (1983) Isolation of multigene families and determination of homologies by filter hybridization methods. In Wu, R., Grossman, L., Moldave, K. (eds.) Methods of Enzymology, Vol. 100 Academic Press, New York pp.266-285. 48 WO 2010/147879 PCT/US2010/038482 Bown, D. P., Wilkinson, H. S., Jongsma, M. A., Gatehouse, J. A. (2004) Characterisation of cysteine proteinases responsible for digestive proteolysis in guts of larval western corn rootworm (Diabrotica virgifera) by expression in the yeast Pichia pastoris. Insect Biochem. Molec. Biol. 34,:305-320. Bravo, A., Gill, S. S., Soberon, M. (2007) Mode of action of Bacillus thuringiensis Cry and Cyt toxins and their potential for insect control. Toxicon 49:423-435. Caruthers, M. H., Kierzek, R., Tang, J. Y. (1987) Synthesis of oligonucleotides using the phosphoramidite method. Bioactive Molecules (Biophosphates Their Analogues) 3:3-21. Christeller, J. T., Laing, W. A., Markwick, N. P., Burgess, E. P. J. (1992) Midgut protease activities in 12 phytophagous lepidopteran larvae: dietary and protease inhibitor interactions. Insect Biochem. Molec. Biol. 22:735-746. Chu, C. C., Wand, C. C., Sun, C. S., Hsu, C., Yin, K. C., Chu, C. Y., Bi, F. Y. (1975) Establishment of an efficient medium for anther culture of rice through comparative experiments on the nitrogen sources. Scientia Sinica 18:659-668. Crameri, A., Cwirla, S., Stemmer, W. P. C. (1996a) Construction and evolution of antibody-phage libraries by DNA shuffling. Nat. Med. 2:100-103. Crameri, A., Dawes, G., Rodriguez, E., Silver, S., Stemmer, W.P.C. (1997) Molecular evolution of an arsenate detoxification pathway by DNA shuffling. Nat. Biotech. 15:436-438. Crameri, A., Whitehom, E.A., Tate, E., Stemmer, W. P. C. (1996b) Improved green fluorescent protein by molecular evolution using DNA shuffling. Nat. Biotech. 14:315-319. de Maagd, R. A., Kwa, M. S., van der Klei, H., Yamamoto, T., Schipper, B., Vlak, J. M., Stiekema, W. J., Bosch, D. (1996) Domain III substitution in Bacillus thuringiensis delta endotoxin CryIA(b) results in superior toxicity for Spodoptera exigua and altered membrane protein recognition. Appl. Environ. Microbiol. 62:1537-1543. de Maagd, R. A., Bravo, A., Berry, C., Crickmore, N., Schnepf, E. (2003) Structure, diversity, and evolution of protein toxins from spore-forming entomopathogenic bacteria. Annu. Rev. Genet. 37:409-433. 49 WO 2010/147879 PCT/US2010/038482 Diaz-Mendoza, M., Farinos, G. P., Castanera, P., Hernandez-Crespo, P., Ortego, F. (2007) Proteolytic processing of native CrylAb toxin by midgut extracts and purified trypsins from the Mediterranean corn borer Sesamia nonagrioide. J. Insect Physiol. 53:428-435. Ellis, R. T., Stockhoff, B. A., Stamp, L., Schnepf, H. E., Schwab, G. E., Knuth, M., Russell, J., Cardineau, G. A., Narva, K. E. (2002) Novel Bacillus thuringiensis binary insecticidal crystal proteins active on western corn rootworm, Diabrotica virgifera virgifera LeConte. Appl. Environ. Microbiol. 68:1137-1145. Englemann, F., Geraerts, W. P. M., (1980) The proteases and the protease inhibitor in the midgut of Leucophaea maderae. J. Insect Physiol. 261:703-710. Fraley, R. T., Rogers, S. G., Horsch, R. B. (1986) Genetic transformation in higher plants. Crit. Rev. Plant Sci. 4:1-46. Gazit, E., La Rocca, P., Sansom, M. S. P., Shai, Y. (1998) The structure and organization within the membrane of the helices composing the pore-forming domain of Baicllus thuringiensis delta-endotoxin are consistent with an "umbrella-like" structure of the pore. Proc. Nat. Acad. Sci. USA 95:12289-12294. Ge, A., Rivers, D., Milne, R., Dean, D. H. (1991) Functional domains of Bacillus thuringiensis insecticidal crystal proteins. Refinement of Heliothis virescens and Trichoplusia ni specificity domains on CryIA(c). J. Biol. Chem. 266:17954-17958. Gillikin, J. W., Bevilacqua, S., Graham, J. S. (1992) Partial characterization of digestive tract proteinases from western corn rootworm larvae, Diabrotica virgifera. Arch. Insect Biochem. Physiol. 19:285-298. Gomez, I., Sanchez, J., Miranda, R., Bravo, A., Soberon, M. (2002) Cadherin-like receptor binding facilitates proteolytic cleavage of helix alpha-i in domain I and oligomer pre pore formation of Bacillus thuringiensis CrylAb toxin. FEBS Lett. 513:242-246. Haider, M. Z., Knowles, B. H., Ellar, D. J. (1986) Specificity of Bacillus thuringiensis var. colmeri insecticidal 6-endotoxin is determined by differential proteolytic processing of the protoxin by larval gut proteases. Eur. J. Biochem. 156:531-540. Heckel, D. G., Gahan, L. J., Baxter, S. W., Zhao, J-Z., Shelton, A. M., Gould, F., Tabashnik, B. E. (2007) The diversity of Bt resistance genes in species of Lepidoptera. J. Invert. Pathol. 95:192-197. 50 WO 2010/147879 PCT/US2010/038482 Hepburn, A. G., White, J., Pearson, L., Maunders, M. J., Clarke, L. E., Prescott, A. G. Blundy, K. S. (1985) The use of pNJ5000 as an intermediate vector for the genetic manipulation of Agrobacterium Ti-plasmids. J. Gen. Microbiol. 131:2961-2969. Hoagland, D. R., Arnon, D. I. (1950) The water-culture method of growing plants without soil. Calif. Agr. Expt. Sta. Circ. 347. Hofte, H., de Greve, H., Seurinck, J., Jansens, S., Mahillon, J., Ampe, C., Vandekerckhove, J., Vanderbruggen, H., van Montagu, M., Zabeau, M., Vaeck, M. (1986) "Structural and functional analysis of a cloned delta endotoxin of Bacillus thuringiensis berliner 1715." Eur. J. Biochem. 161:273-280. Hon6e, G., Convents, D., Van Rie, J., Jansens, S., Peferoen, M., Visser, B. (1991) The C terminal domain of the toxic fragment of a Bacillus thuringiensis crystal protein determines receptor binding. Mol. Microbiol. 5:2799-2806 Horton, R.M., Hunt, H.D., Ho, S.N., Pullen, J.K., Pease, L.R. (1989) Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68. Huang, F., Rogers, L. B., Rhett, G. H. (2006) Comparative susceptibility of European corn borer, southwestern corn borer, and sugarcane borer (Lepidoptera: Crambidae) to CrylAb protein in a commercial Bacillus thuringiensis corn hybrid. J. Econ. Entomol. 99:194-202. Huang, K-X., Badger, M., Haney, K., Evans, S. L. (2007) Large scale production of Bacillus thuringiensis PS149B1 insecticidal proteins Cry34Abl and Cry35Abl from Pseudomonasfluorescens. Prot. Express. Purific. 53:325-330. Janmaat, A. F., Myers, A. H. (2003) Rapid evolution and the cost of resistance to Bacillus thuringiensis in greenhouse populations of cabbage loopers, Trichoplusia ni. Proc. Royal Soc. London. Ser. B, Biolog. Sci. 270:2263-2270. Janmaat, A. F., Myers, A. H. (2005) The cost of resistance to Bacillus thuringiensis varies with the host plant of Trichoplusia ni. Proc. Royal Soc. London. Ser. B, Biolog. Sci. 272:1031-1038. Karlin, S., Altschul, S. F. (1990) Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes. Proc. Natl. Acad. Sci. USA 87:2264-2268. 51 WO 2010/147879 PCT/US2010/038482 Karlin, S., Altschul, S. F. (1993) Applications and statistics for multiple high-scoring segments in molecular sequences. Proc. Natl. Acad. Sci. USA 90:5873-5877. Keller, G.H., Manak, M. M. (1993) DNA Probes, Background, Applications, Procedures. Stockton Press, New York, NY. Knight, J. S., Broadwell, A. H., Grant, W. N., Shoemaker, C. B. (2004) A Strategy for Shuffling Numerous Bacillus thuringiensis Crystal Protein Domains. J. Econ. Entomol. 97:1805 1813. Koiwa, H., Shade, R. E., Zhu-Salzman, K., D'Urzo, M. P., Murdock, L. L., Bressan, R. A., Hasegawa, P. M. (2000) A plant defensive cystatin (soyacystatin) targets cathepsin L-like digestive cysteine proteinases (DvCALs) in the larval midgut of western corn rootworm Diabrotica virgifera virgifera. FEBS Letters 471:67-70. Larson, S. M., England, J. L., Desjarlais, J. R., Pande, V. S. (2002) Thoroughly sampling sequence space: Large-scale protein design of structural ensembles. Protein Sci. 11:2804-2813. Lee, L.-Y., Gelvin, S. B. (2008) T-DNA binary vectors and systems. Plant Physiol. 146: 325-332. Linsmaier, E.M., Skoog, F. (1965) Organic growth factor requirements of tobacco tissue. Physiologia Plantarum 18:100-127. Littlefield, J. W. (1964) Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants. Science 145:709-710. Meinkoth, J., Wahl, G. (1984) Hybridization of nucleic acids immobilized on solid supports. Anal. Biochem. 138:267-284. Metcalf, R. L. (1986) The ecology of insecticides and the chemical control of insects. pp. 251-297. In (Marcos Kogan (ed.)) Ecological theory and integrated pest management practice. John Wiley & Sons, N. Y. 362 pp. 52 WO 2010/147879 PCT/US2010/038482 Moellenbeck, D. J., Peters, M. L., Bing, J. W., Rouse, J. R., Higgins, L. S., Sims, L., Nevshemal, T., Marshall, L., Ellis, R. T., Bystrak, P. G., Lang, B. A., Stewart, J. L., Kouba, K., Sondag, V., Gustafson, V., Nour, K., Xu, D., Swenson, J., Zhang, J., Czapla,T., Schwab, G., Jayne, S., Stockhoff, B. A., Narva, K., Schnepf, H. E., Stelman, S. J., Poutre, C., Koziel, M., Duck, N. (2001) Insecticidal proteins from Bacillus thuringiensis protect corn from corn rootworms. Nat. Biotech. 19:668 - 672. Myers, E., Miller, W. (1988) Optimal alignments in linear space. CABIOS 4:11-17. Naimov, S., Weemen-Hendriks, M., Dukiandjiev, S., de Maagd, R.A. (2001) Bacillus thuringiensis delta-endotoxin Cryl hybrid proteins with increased activity against the Colorado Potato Beetle. Appl. Environ. Microbiol. 11:5328-5330. Needleman, S. B., Wunsch, C. D. (1970) A general method applicable to the search for similarities in the amino acid sequence of two proteins. J. Mol. Biol. 48:443-453. Nunez-Valdez, M.-E., Sanchez, J., Lina, L., Guereca, L., Bravo, A. (2001) Structural and functional studies of alpha-helix 5 region from Bacillus thuringiensis CrylAb delta-endotoxin. Biochim. Biophys. Acta, Prot. Struck. Molec. Enzymol. 1546:122-131. Ochoa-Campuzano, C., Real, M. D., Martinez-Ramirez, A. C., Bravo, A., Rausell, C. (2007) An ADAM metalloprotease is a Cry3Aa Bacillus thuringiensis toxin receptor. Biochem. Biophys. Res. Commun. 362:437-442. Pigott, C. R., Ellar, D. J. (2007) Role of receptors in Bacillus thuringiensiscrystal toxin activity. Microbiol. Molec. Biol. Rev. 71:255-281. Rang, C., Vachon, V., de Maagd, R. A., Villalon, M., Schwartz, J.-L., Bosch, D., Frutos, R., Laprade R. (1999) Interaction between functional domains of Bacillus thuringiensis insecticidal crystal proteins. Appl. Environ. Microbiol. 65:2918-2925. Sambrook, J., Fritsch, E. F., Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual (2nd ed., Cold Spring Harbor Laboratory Press, Plainview, N.Y.) Schenk, R. U., Hildebrandt, A. C. (1972) Medium and techniques for induction and growth of monocotyledonous and dicotyledonous plant cell cultures. Can. J. Bot. 50:199-204 53 WO 2010/147879 PCT/US2010/038482 Schnepf, H. E., Tomczak, K., Ortega, J. P., Whiteley, H. R. (1990) Specificity determining regions of a Lepidopteran-specific insecticidal protein produced by Bacillus thuringiensis. J. Biol. Chem. 265:20923-20930. Soberon, M., Pardo-Lopez, L., Lopez, I., Gomez, I., Tabashnik, B. E., Bravo, A. (2007) Engineering modified Bt toxins to counter insect resistance. Science 318:1640-1642. Squires, C. H., Retallack, D. M., Chew, L. C., Ramseier, T. M., Schneider, J. C., Talbot, H. W. (2004) Heterologous protein production in P. fluorescens. Bioprocess Intern. 2:54-59. Stemmer, W. P .C. (1994a) DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. Proc. Natl. Acad. Sci. USA 91:10747-10751 Stemmer, W. P .C. (1994b) Rapid evolution of a protein in vitro by DNA shuffling. Nature 370: 389-391. Stemmer, W. P. C. (1995) Searching sequence space. Bio/Technology 13:549-553. Stewart, L. (2007) Gene synthesis for protein production. Encylopedia of Life Sciences. John Wiley and Sons, Ltd. Stewart, L., Burgin, A. B., (2005) Whole gene synthesis: a gene-o-matic future. Frontiers in Drug Design and Discovery 1:297-341. Suggs, S.V., Miyake, T., Kawashime, E. H., Johnson, M. J., Itakura, K., R.B. Wallace, R. B. (1981) ICN-UCLA Symposium. Dev. Biol. Using Purified Genes, D. D. Brown [ed.], Academic Press, New York, 23:683-69 Tabashnik, B. E., Finson, N., Groeters, F. R., Moar, W. J., Johnson, M. W., Luo, K., Adang, M. J. (1994) Reversal of resistance to Bacillus thuringiensis in Plutella xylostella. Proc. Nat. Acad. Sci. USA 91:4120-4124. Tabashnik, B. E., Gassmann, A. J., Crowder, D. W., Carriere, T. (2008) Insect resistance to Bt crops: evidence versus theory. Nat. Biotech. 26:199-202. Taggart, R. T., Samloff, I. M. (1983) Stable antibody-producing murine hybridomas. Science 219:1228-1230. 54 WO 2010/147879 PCT/US2010/038482 Thie, N. M. R., Houseman J. G. (1990) Identification of cathepsin B, D and H in the larval midgut of Colorado potato beetle, Leptinotarsa decemlineata say (Coleoptera: Chrysomelidae) Insect Biochem. 20:313-318. Thompson, J. D., Higgins, D. G., Gibson, T. J. (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice. Nucl. Acids Res. 22:4673-4680. Tijssen, P. (1993) Laboratory Techniques in Biochemistry and Molecular Biology Hybridization with Nucleic Acid Probes, Part I, Chapter 2. P. C. van der Vliet [ed.], (Elsevier, N.Y.) Varshavsky, A. (1997) The N-end rule pathway of protein degradation. Genes to Cells 2:13-28. Vaughn, T., Cavato, T., Brar, G., Coombe, T., DeGooyer, T., Ford, S., Groth, M., Howe, A., Johnson, S., Kolacz, K., Pilcher, C., Prucell, J., Romano, C., English, L., Pershing, J. (2005) A method of controlling corn rootworm feeding using a Bacillus thuringiensis protein expressed in transgenic maize. Crop. Sci. 45:931-938. Walters, F. S., Slatin, S. L., Kulesza, C. A., English, L. H. (1993) Ion channel activity of N-terminal fragments from CryIA(c) delta-endotoxin. Biochem. Biophys. Res. Commun. 196:921-926. Walters, F. S., Stacy, C. M., Lee, M. K., Palekar, N., Chen, J. S. (2008) An engineered chymotrypsin/cathepsin G site in domain I renders Bacillus thuringiensis Cry3A active against western corn rootworm larvae. Appl. Environ. Microbiol. 74:367-374. Wehrmann, A., Van Vliet, A., Opsomer, C., Botterman, J., Schulz, A. (1996) The similarities of bar and pat gene products make them equally applicable for plant engineers. Nat. Biotechnol. 14:1274-1278. Weigel, D., Glazebrook, J. [eds.] (2002) Arabidopsis: A Laboratory Manual. Cold Spring Harbor Press, Cold Spring Harbor, NY, 354 pages. Wolfson, J. L., Murdock, L. L. (1990) Diversity in digestive proteinase activity among insects. J. Chem. Ecol. 16:1089-1102. 55 WO 2010/147879 PCT/US2010/038482 Worley, C. K., Ling, R., Callis, J. (1998) Engineering in vivo instability of firefly luciferase and Escherichia coli P-glucuronidase in higher plants using recognition elements from the ubiquitin pathway. Plant Molec. Biol. 37:337-347. 56
Claims (16)
1. An isolated polypeptide comprising a core toxin segment selected from the group consisting of (a) a polypeptide comprising the amino acid sequence of residues 97 to 631 of SEQ ID NO:2; (b) a polypeptide comprising an amino acid sequence having at least 90% sequence identity to the amino acid sequence of residues 97 to 643 of SEQ ID NO:2; (c) a polypeptide comprising an amino acid sequence of residues 97 to 631 of SEQ ID NO:2 with up to 20 amino acid substitutions, deletions, or modifications that do not adversely affect expression or activity of the toxin encoded by SEQ ID NO:2; or an insecticidally active fragment thereof.
2. An isolated polypeptide of claim 1 comprising a core toxin segment selected from the group consisting of (a) a polypeptide comprising the amino acid sequence of residues 1 to 631 of SEQ ID NO:2; (b) a polypeptide comprising an amino acid sequence having at least 90% sequence identity to the amino acid sequence of residues 1 to 631 of SEQ ID NO:2; (c) a polypeptide comprising an amino acid sequence of residues 1 to 631 of SEQ ID NO:2 with up to 20 amino acid substitutions, deletions, or modifications that do not adversely affect expression or activity of the toxin encoded by SEQ ID NO:2; or an insecticidally active fragment thereof.
3. A plant comprising the polypeptide of claim 1.
4 A plant comprising the polypeptide of claim 2. 57 WO 2010/147879 PCT/US2010/038482
5. A method for controlling a pest population comprising contacting said population with a pesticidally effective amount of the polypeptide of claim 1.
6. An isolated nucleic acid that encodes a polypeptide of claim 1.
7. An isolated nucleic acid that encodes a polypeptide of claim 2.
8. An isolated nucleic acid of claim 6 of SEQ ID NO:1 or SEQ ID NO:3.
9. A polypeptide of claim 1 of SEQ ID NO:2 or SEQ ID NO:5.
10. A DNA construct comprising the nucleotide sequence of claim 6 operably linked to a promoter that is not derived from Bacillus thuringiensis and is capable of driving expression in a plant.
11. A transgenic plant that comprises the DNA construct of claim 10 stably incorporated into its genome.
12. A method for protecting a plant from a pest comprising introducing into said plant the construct of claim 10.
13. A polypeptide of claim 1 or 2 having activity against corn rootworm.
14. The transgenic plant of claim 11 wherein said transgenic plant comprises a dsRNA for suppression of an essential gene in corn rootworm.
15. The transgenic plant of claim 14 wherein said essential gene is selected from the group consisting of vacuolar ATPase, ARF-1, Act42A, CHD3, EF-laL, and TFIIB.
16. The transgenic plant of claim 11 wherein said transgenic plant comprises a dsRNA for suppression of an essential gene in an insect pest. 58
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18743609P | 2009-06-16 | 2009-06-16 | |
US61/187,436 | 2009-06-16 | ||
PCT/US2010/038482 WO2010147879A1 (en) | 2009-06-16 | 2010-06-14 | Dig-10 insecticidal cry toxins |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2010260304A1 true AU2010260304A1 (en) | 2011-12-15 |
Family
ID=43307601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2010260304A Abandoned AU2010260304A1 (en) | 2009-06-16 | 2010-06-14 | DIG-10 insecticidal Cry toxins |
Country Status (16)
Country | Link |
---|---|
US (2) | US8697642B2 (en) |
EP (1) | EP2443141A4 (en) |
JP (1) | JP2012529911A (en) |
KR (1) | KR20120046168A (en) |
CN (1) | CN102439029A (en) |
AR (1) | AR077095A1 (en) |
AU (1) | AU2010260304A1 (en) |
BR (1) | BRPI1011304A2 (en) |
CA (1) | CA2765742A1 (en) |
CL (1) | CL2011003185A1 (en) |
CO (1) | CO6470902A2 (en) |
MX (1) | MX2011013673A (en) |
NZ (1) | NZ596658A (en) |
RU (1) | RU2012101277A (en) |
WO (1) | WO2010147879A1 (en) |
ZA (1) | ZA201108946B (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9234208B1 (en) * | 2010-05-10 | 2016-01-12 | Dow Agrosciences Llc | DIG-13 insecticidal cry toxins |
MX345613B (en) | 2010-12-30 | 2017-02-07 | Dow Agrosciences Llc | Nucleic acid molecules that confer resistance to coleopteran pests. |
EP2658975A4 (en) | 2010-12-30 | 2014-10-22 | Dow Agrosciences Llc | Nucleic acid molecules that target the vacuolar atpase h subunit and confer resistance to coleopteran pests |
AP2013007020A0 (en) | 2010-12-30 | 2013-07-31 | Dow Agrosciences Llc | Nucleic acid molecules that target the vacuolar aptase C subunit and confer resistance to coleopteran pests |
JP2014503218A (en) | 2010-12-30 | 2014-02-13 | ダウ アグロサイエンシィズ エルエルシー | A nucleic acid molecule that targets Rho1 small GTP-binding protein and confers resistance to Coleoptera pests |
WO2014090765A1 (en) | 2012-12-12 | 2014-06-19 | Bayer Cropscience Ag | Use of 1-[2-fluoro-4-methyl-5-(2,2,2-trifluoroethylsulfinyl)phenyl]-5-amino-3-trifluoromethyl)-1 h-1,2,4 tfia zole for controlling nematodes in nematode-resistant crops |
CN106455545B (en) | 2014-06-20 | 2021-03-09 | 美国陶氏益农公司 | Vegetative insecticidal proteins useful for controlling insect pests |
CN105368733B (en) * | 2014-08-28 | 2019-02-26 | 四川农业大学 | One bacillus thuringiensis strain new strains and its application |
WO2016057123A1 (en) | 2014-08-28 | 2016-04-14 | Dow Agrosciences Llc | Dig-17 insecticidal cry toxins |
US20160060306A1 (en) * | 2014-08-28 | 2016-03-03 | Dow Agrosciences Llc | Dig-14 insecticidal cry toxins |
US10316329B2 (en) | 2014-10-16 | 2019-06-11 | Monsanto Technology Llc | Proteins toxic or inhibitory to lepidopteran insects |
KR102127553B1 (en) | 2014-10-16 | 2020-06-29 | 몬산토 테크놀로지 엘엘씨 | Novel chimeric insecticidal proteins toxic or inhibitory to lepidopteran pests |
JP6648127B2 (en) | 2014-10-16 | 2020-02-14 | モンサント テクノロジー エルエルシー | Lepidopteran active Cry1Da1 amino acid sequence mutant protein |
US10487123B2 (en) | 2014-10-16 | 2019-11-26 | Monsanto Technology Llc | Chimeric insecticidal proteins toxic or inhibitory to lepidopteran pests |
CA2964122A1 (en) | 2014-10-27 | 2016-05-06 | Newleaf Symbiotics, Inc. | Methods and compositions for controlling corn rootworm |
WO2016109214A1 (en) * | 2014-12-30 | 2016-07-07 | Dow Agrosciences Llc | Dig-305 insecticidal cry toxins |
BR112018003695B1 (en) | 2015-08-27 | 2022-12-27 | Monsanto Technology Llc | RECOMBINANT NUCLEIC ACID MOLECULE, USE OF A PLANT, PLANT CELL, PLANT PART, OR SEED COMPRISING THE SAME, INSECT INHIBITOR COMPOSITION, BASE PRODUCT, AND METHODS FOR CONTROLLING A PEST OR PEST INFESTATION OF LEPIDOPTERA SPECIES AND DETECTING THE PRESENCE OF A PESTICIDAL PROTEIN |
CN108070535B (en) * | 2016-11-14 | 2020-10-30 | 华中农业大学 | Bacillus thuringiensis for preventing and treating soybean cyst nematode and meloidogyne incognita, preparation and application |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US10703782B2 (en) * | 2017-01-12 | 2020-07-07 | Monsanto Technology Llc | Pesticidal toxin proteins active against lepidopteran insects |
MX2019011836A (en) * | 2017-04-03 | 2019-11-21 | Monsanto Technology Llc | Novel insect inhibitory proteins. |
WO2022125639A1 (en) | 2020-12-08 | 2022-06-16 | Monsanto Technology Llc | Modified plant-associated bacteria and methods of their use |
CN116670155A (en) | 2020-12-21 | 2023-08-29 | 孟山都技术公司 | Novel insect inhibitory proteins |
UY39585A (en) | 2020-12-23 | 2022-07-29 | Monsanto Technology Llc | PROTEINS THAT EXHIBIT INSECT INHIBITOR ACTIVITY AGAINST PESTS OF AGRICULTURAL IMPORTANCE OF CROP PLANTS AND SEEDS |
AU2021412979A1 (en) | 2020-12-31 | 2023-07-06 | Monsanto Technology Llc | Novel insect inhibitory proteins |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1879913A1 (en) * | 2005-05-02 | 2008-01-23 | Athenix Corporation | Axmi-028 and axmi-029, family of novel delta-endotoxin genes and methods for their use |
EP2439278B1 (en) * | 2005-09-16 | 2016-11-09 | Monsanto Technology LLC | Methods for genetic control of insect infestations in plants and compositions thereof |
EP2455391A3 (en) * | 2006-06-15 | 2012-08-22 | Athenix Corporation | A family of pesticidal proteins and methods for their use |
-
2010
- 2010-06-14 US US12/814,766 patent/US8697642B2/en active Active
- 2010-06-14 RU RU2012101277/10A patent/RU2012101277A/en not_active Application Discontinuation
- 2010-06-14 WO PCT/US2010/038482 patent/WO2010147879A1/en active Application Filing
- 2010-06-14 BR BRPI1011304-5A patent/BRPI1011304A2/en not_active Application Discontinuation
- 2010-06-14 CA CA2765742A patent/CA2765742A1/en not_active Abandoned
- 2010-06-14 EP EP10789990A patent/EP2443141A4/en not_active Withdrawn
- 2010-06-14 MX MX2011013673A patent/MX2011013673A/en active IP Right Grant
- 2010-06-14 KR KR1020127001026A patent/KR20120046168A/en not_active Application Discontinuation
- 2010-06-14 CN CN2010800327282A patent/CN102439029A/en active Pending
- 2010-06-14 AU AU2010260304A patent/AU2010260304A1/en not_active Abandoned
- 2010-06-14 AR ARP100102102A patent/AR077095A1/en unknown
- 2010-06-14 JP JP2012516157A patent/JP2012529911A/en active Pending
- 2010-06-14 NZ NZ596658A patent/NZ596658A/en not_active IP Right Cessation
-
2011
- 2011-12-06 ZA ZA2011/08946A patent/ZA201108946B/en unknown
- 2011-12-15 CL CL2011003185A patent/CL2011003185A1/en unknown
- 2011-12-16 CO CO11173644A patent/CO6470902A2/en not_active Application Discontinuation
-
2013
- 2013-05-17 US US13/897,082 patent/US9487798B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
RU2012101277A (en) | 2013-07-27 |
CL2011003185A1 (en) | 2012-10-19 |
EP2443141A4 (en) | 2013-03-20 |
US8697642B2 (en) | 2014-04-15 |
US20100319092A1 (en) | 2010-12-16 |
AR077095A1 (en) | 2011-08-03 |
CO6470902A2 (en) | 2012-06-29 |
KR20120046168A (en) | 2012-05-09 |
WO2010147879A1 (en) | 2010-12-23 |
EP2443141A1 (en) | 2012-04-25 |
ZA201108946B (en) | 2012-11-28 |
BRPI1011304A2 (en) | 2019-04-09 |
CN102439029A (en) | 2012-05-02 |
US9487798B2 (en) | 2016-11-08 |
MX2011013673A (en) | 2012-01-20 |
US20130247254A1 (en) | 2013-09-19 |
CA2765742A1 (en) | 2010-12-23 |
NZ596658A (en) | 2013-12-20 |
JP2012529911A (en) | 2012-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9487798B2 (en) | DIG-10 insecticidal cry toxins | |
US8304605B2 (en) | DIG-11 insecticidal cry toxins | |
US9006520B2 (en) | DIG-3 insecticidal Cry toxins | |
US8461422B2 (en) | DIG-5 insecticidal Cry toxins | |
US10731176B2 (en) | DIG-305 insecticidal Cry toxins | |
US10028510B2 (en) | DIG-17 insecticidal cry toxins | |
US10876131B2 (en) | Dig-303 insecticidal Cry toxins | |
US9234208B1 (en) | DIG-13 insecticidal cry toxins | |
US20160060306A1 (en) | Dig-14 insecticidal cry toxins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |